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ABSTRACT
The discovery of the Clustered Regularly Interspaced Short Palindromic
Repeats (CRISPR) family of genome sequences in bacteria and archaea has led
to expansive application of the system as a means of interrogating and modifying
genetic material across all kingdoms of life. This dissertation has developed
algorithms and accompanying software, collectively named CASPER (CRISPR
Associated Software for Pathway Engineering and Research), to identify promising
sequences for effectively utilizing CRISPR associated (Cas) proteins in any
species or community/metagenome of interest. The on- and off-target activity
scoring algorithms improve upon previous work, first by utilizing an evolutionary
algorithm and then by employing protein simulation to identify the contribution of
sequence stability and mismatches to overall activity. Two algorithms,
multitargeting and population analyses, employ searches across multiple genomes
for deploying both degenerate and specific guides with immediate application in
microbiome manipulation and CRISPR-Cas enabled rapid sequence detection
assays. Finally, the CASPERpam algorithm was written to rapidly identify potential
protospacer adjacent motifs (PAM) that are required for initial binding by Cas
proteins/complexes. CASPERpam successfully re-identified 12 experimental PAM
sequences and further identified putative PAM sequences for another 1,037
species.
The application of CRISPR-Cas as an antimicrobial is of immediate interest
due to rising prevalence of antibiotic resistance and the associated costs of
development. Using the aforementioned algorithms for sequence design, this
dissertation identified key barriers and opportunities for development of novel
CRISPR-Cas antimicrobials that are both highly specific and highly tunable.
Specifically, the identification of kinetic limitations to the transient introduction and
expression of CRISPR-Cas machinery is a key mechanism of cell persistence.
Studies in both model yeast (Saccharomyces cerevisiae) and multiple species of
bacteria (Escherichia coli, Bacillus subtilis, and Staphylococcus aureus) highlight
the benefits of co-targeting defensive genes with high turnover rate Cas enzymes
as a means of mitigating such kinetic barriers. These design principles are
inherently generalizable to multiple pathogenic species, and benefit from the
inherent specificity of CRISPR-Cas sequences to lay the foundation for a powerful
new class of antimicrobials.
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CHAPTER ONE
INTRODUCTION
General Overview
The purpose of this thesis is to lay out a framework for marrying principles of
engineering with the rise of CRISPR-Cas as a means of manipulating a variety of
organisms in diverse environments1. This combinatorial space is poorly suited to
examination with traditional pedagogies of biological research. While many
fundamental principles and governing dynamics remain elusive in each field, taking
an engineering approach to solve some of the more complex problems can not
only serve as a useful interdisciplinary lens, but also streamline the deployment of
impactful applications to tackle problems ranging from disease epidemics to
biodiversity loss and agricultural stress from climate change. It is the hope of the
author and his collaborating researchers that the tools and techniques stemming
from this research will aid in fulfilling more promises and evading pitfalls facing the
deployment of CRISPR-Cas as it moves into its next frontier.

The Rise of CRISPR-Cas
The Race Begins
While the existence of the CRISPR (Clustered Regularly Interspaced Short
Palindromic Repeats) array and its associated (Cas) open reading frames (ORFs)
had been known since the 1990s2, their biochemical nature was a mystery until
2009 when Francis Mojica inferred its functionality as an adaptive immune system
by mapping the sequences in the array (the spacers) to known sequences from
bacteriophages2,3. Mojica et al. in 2009 also inferred that these sequences were
specifically acquired, as suggested by the presence of integrase-like proteins
nearby3. Further identification of nuclease domains in the nearby ORFs suggested
that the proteins were being honed to viral sequences for destruction4. Shortly
following the discovery of DNA as a target molecule, the full characterization of the
homing complex was elucidated and its biochemistry quickly began to be applied
to other systems by heterologously expressing the necessary machinery5-7. The
final piece of the puzzle for potential widespread application was the innovation of
the fusing of the two necessary RNA fragments, the crRNA (CRISPR RNA) and
the tracrRNA (trans-activating RNA) into a single RNA that could be easily
expressed from a single RNA Polymerase III promoter8. The potential impact of a
system that could program an enzyme complex to a specific site in the genome
with the use of a simple 20-30 nucleotide RNA sequence was immediately
recognized as a transformative technology in biology7-10. Within 10 years from the
initial functional discovery, CRISPR-Cas had become a household name.

1

CRISPR-Cas Mechanisms and Biology
CRISPR-Cas utilizes a network of nucleic acid interacting enzymes to form an
adaptive immunity system and is present in the majority of bacteria and archaea.
Briefly, upon infection from a bacteriophage, the surveying Cas1 and Cas2
proteins identify the sequence and use their transposase and integrase
functionalities to copy a section of the phage genome into the CRISPR array within
the bacterial genome (Figure 1, All figures appear in Appendix)11. By integrating
into the genome, the sequence is saved for future reference should the bacterium
see the invading sequence again (the adaptive immune response). The CRISPR
array is then transcribed into RNA and then processed by other accompanying
Cas genes into mature crRNA sequences. These crRNAs then combine with the
Cas nuclease complex, and the entire ribonucleoprotein (RNP) is directed to the
foreign DNA (or RNA) sequence via sequence complementarity with the crRNA12.
The diversity of CRISPR-Cas systems is classified into 2 classes, 6 types,
and 24 subtypes (Figure 2)1,12. Class 1 systems are the multi-effector nucleases
and are comprised of the Types I and III13,14. From phylogenetic analysis, Type IV
is also classified into Class 1; however, the mechanism of this type remains
cryptic15-17. Structurally, Type I and III are similar, as they both rely on a multieffector complexes to induce cleavage but exhibit distinct functionalities 18. Type I
systems are defined by their multi-effector recognition complexes that bind the
crRNA and DNA followed by recruitment of the Cas3 helicase/nuclease protein. In
contrast, Type III systems rely on the Cas10 protein for transcribed RNA
recognition and cleavage, and use recruitment of Csm/Cmr subunits to stabilize
the structure in between recognition and cleavage5,14,17,19.
Class 2 contains the single-effector nucleases of Type II, V, and VI14,17.
These systems have been widely co-opted for heterologous expression due to
their single-effector nature, which—along with the guide-RNA—requires just a
single protein to be expressed for recognition and cleavage. This capability was
quickly realized by multiple groups using the Cas9 (Type II) protein from
Streptococcus pyogenes (spCas9, II-A)8,9,20. Coincidentally, this Cas9 proved to
be the most robust across all multiple organisms and in vitro assays, making it the
most well-studied system to-date21. Due to the large size of the spCas9 (160kDa)
other smaller Cas9 orthologs have been sought to be optimized so they could be
more readily packaged for lenti- or adenoviral delivery22-24. Common to all Cas9
is their use of trans-activating (tracrRNA) to complex with the crRNA and form a
double-strand break (DSB) in the DNA substrate8,24. In contrast, Type V systems
lack a tracrRNA, and create a staggered cut on the DNA. These proteins were
discovered by the Zhang group at the Broad Institute25 in the Acidaminococcus
spp. and were given the name Cpf1 before being redesignated Cas12 to match
the nomenclature of the expanding suite of CRISPR-Cas systems17. Type VI is
the most recently discovered class and is quite unique from Type II (Cas9’s) and
Type V (Cas12’s) as it cleaves single-stranded RNA (ssRNA), while also exhibiting
trans nuclease activity on non-target ssRNA once activated via target binding26,27.
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Predicting CRISPR-Cas Behavior
Like its predecessors, the Zinc Finger Nucleases (ZFNs) and transcription activator
like endonucleases (TALENs)28, CRISPR-Cas directed targeting of genetic
elements requires the design of a homing sequence. Prior to CRISPR-Cas, such
tools took the shape of identifying the correct order of short DNA sequence
recognition proteins and assembling them together to make more specific arrays.
With CRISPR-Cas, the combinatorial space available (4n, n = length of RNA
guiding sequence) requires a different and more facile approach to rational design.
In addition, the ease of producing a vast library of sequence variants enables the
use of high-throughput screening methods to assay activity. Many such studies
exist, using a variety of host organisms/cell lines, and more recently different Cas
endonucleases25,29-33.
While nuances exist in each study, the general
experimental layout follows a similar procedure. First, a library of sequences is
generated from oligo synthesis. This group of oligomers is then transformed into
a cell line of interest, and their activity is assayed either through the existence of a
certain phenotype (e.g. GFP fluorescence, cell morphology) or through a more
quantitative sequencing of the target DNA or sgRNA distribution profile.
Phenotypic assays are most commonly used to detect on-target activity, defined
as the activity from a perfect sgRNA/DNA match 29,31. On the other hand, off-target
activity—activity at a non-perfect sgRNA/DNA site—is most commonly detected
through DNA re-sequencing of closely matched target sites, or the more expensive
but unbiased genome-wide mutation assay34-36.
While the aforementioned studies were designed to identify design rules for
making highly active guide-RNAs, their combined results seem to indicate that
such a rational workflow for predicting what is referred to as on-target activity
remains elusive. Elements of certain studies have identified the possible reasons
for the difficulty in ascertaining general design rules 37. In one study38, the state of
supercoiling of a plasmid was shown to drastically affect cleavage by a Cas9
ortholog, suggesting the state of DNA superstructure may play a role in governing
activity. This is further supported by seminal FRET analyses by Doudna and
colleagues that showed the R-loop formation—when the ribonucleoprotein
complex binds to the double stranded DNA and unwinds it—as the energetically
limiting factor to activity39. A DNA coiling that reduces this thermodynamic barrier
would lead to more facile binding and therefore greater activity at such sites.
Genomic DNA contains a great variation in superstructure, which is used in many
organisms to regulate gene expression in concert with traditional protein-based
transcriptional regulation40. Of note, nucleosomes (i.e., histones) are essential
elements in packing genetic material, but have been shown to reduce DNA
accessibility to CRISPR-Cas nucleases41,42. To further complicate the endeavor,
global genomic structure is subject to the stages of cell growth, while local regions
can be further modulated based on specific environmental conditions.
Understanding the complex interplay of these factors in genomes of multiple
organisms with multiple cell types is a near insurmountable task with current
methodologies, so the focus on the relative activity of a particular guide-RNA
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sequence is a necessity. Mendoza et al. (see Chapter 2) coined the terms relative
and absolute activity, referring to the activity that can be assigned purely to the
guide-RNA sequence holding all other factors constant, which is predictable, in
contrast to the absolute activity, which is experimentally observable 43. The ability
to deconvolute the relative from the absolute activity is a subject of active research,
with a variety of models using advanced machine learning techniques to more
accurately assign relative activity scores based on canonical experimental
datasets44-47. Ultimately, the ability to tile multiple guides across the desired locus
target to determine the best performing sequence is a cost and time efficient
experiment, which limits the utility of on-target prediction algorithms. However, the
ability to identify potential off-target sites is of paramount importance, as assaying
genome-wide off-target activity for a large number of guides can quickly become
intractable experimentally28.
Off-target activity, defined as the non-specific activity at sites that contain
mismatches between the guide-RNA and targeted DNA, has been a key limitation
in the deployment of CRISPR-Cas in many of its potential applications, particularly
therapeutics43,48. Early studies began investigating the promiscuity of Cas
enzymes, with the majority of the focus on spCas9 36. Due to the variation in cell
types and experimental conditions confounding absolute activity, assays from
different groups led to different conclusions regarding Cas enzyme propensity for
off-target activity35,49,50.
The location of the potential off-target activity is relevant to its assessment
as a potential risk. An identified off-target site that is located on a crucial gene that
would result in silencing or harmful mutation, faces a much stricter cutoff than one
that is located in an isolated topologically associated domain (TAD) on a noncoding sequence28,51. Streamlining the integration of this assessment in the well
curated genomes (e.g., human, mouse) will be an important next step in off-target
activity analysis by adding a risk variable to the prediction exercise.
Orthologs and applications of their functionalities
Despite the ubiquity of spCas9, other orthologs have been recently gaining
attention for their unique chemistries that enable the development of novel
applications (see Figure 2 for summary). The Type I and III systems show promise
for harnessing endogenous systems. They also hold promise due to their
decoupled nuclease activity from their recognition domain, allowing potential
modulation via a recruitment effect13,18. Type V systems, of which Cas12 (formerly
Cpf1) belongs, is quite similar to Cas9 in its single-effector structure and doublestranded DNA substrate25. Recently, the discovery of trans-nuclease activity in
many Cas12 enzymes has suggested it holds promise in a variety of new
applications, particularly that of antimicrobials and DNA identification and
degradation33. Finally, the Type VI endonucleases (Cas13 family) targets a singlestranded RNA substrate and exhibits robust trans nuclease activity 26,52. Unlike
their Cas12 cousins, the trans nuclease domain is separate from the endonuclease
domain, which is thought to contribute to its broader trans activity. Cas13s have
4

been deployed to great effect as sensitive nucleic acid biosensors, utilizing this
trans activity to cleave synthetic indicator RNA analogs mixed into a sample 53,54.
This capability shows promise for a new generation of rapid biological detectors,
with applications ranging from prompt pathogen identification to environmental
profiling.
Engineering new types of Cas
CRISPR-Cas’s “find” capability is arguably its most powerful. Despite ZFNs and
TALENs also sharing in this ability, their functionality is limited due to their involved
multimeric assembly. Single-effector CRISPR-Cas systems (Type II,V,VI), contain
only 1-2 nuclease domains that can be easily inactivated with point mutations,
rendering catalytically dead proteins that only bind the DNA55. Multi-effector
systems (Type I,III) can also be rendered catalytically inactive through the
knockout of the separated nuclease enzymes (e.g. Cas3)13. These dCas proteins
are used to great effect in gene knockdown assays and can be combined with a
variety of experimental conditions to identify relevant pathways for inducing certain
phenotypes. So widespread are such assays that the procedure is commonly
referred to as CRISPRi (CRISPR inactivation/inhibition) 56. As expected, the
placement of the target sequence relative to key elements in the operon (promoter,
start codon, ribosome binding site, introns, etc.) is key to effective inhibition57. As
such, a multitude of software tools have dedicated CRISPRi algorithms for
designing appropriate targets.
Some studies have decided to take CRISPRi a step further, by fusing to the
N-terminus a transcriptional repressor such as KRAB, enhancing the inhibitory
effect. On the opposite end, activator proteins such as VP64 can be fused to
dCas9, creating a gene-activator complex in a process known as CRISPRa
(CRISPR activation)58. To add even further combinatorics, other Cas9/Cas12
orthologs have also been fused with repressors and activators and show varying
degrees of activity relative to their spCas9 counterparts providing a near-analog
toolkit for designing gene regulation elements with CRISPR-Cas59.
Recently, the development of adenine and cytosine deaminase domains
fused to a spCas9 nickase (one catalytic domain knocked out resulting in doublestrand nicking) has produced a novel functionality of precisely directed point
mutations. The unwinding of DNA by Cas9 and nickase activity allows the
deaminases to target bases in the 12-16 nucleotide PAM-distal region of the DNA
sequence60. The precise sequence requirements for base editing prompted further
engineering to decrease PAM specificity to make available more sites in the
genome able to be editing by a CRISPR-Cas base editor61. Due to the large
number of human diseases associated with point mutations, this technology is a
promising new direction for clinical deployment of CRISPR-Cas.
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CRISPR-Cas as Antimicrobials
Targeting Bacteria with CRISPR-Cas
While CRISPR-Cas is native to prokaryotes, the immediate attention of its
applicability was turned to the promise of heterologous deployment in relevant
eukaryotes for facilitating gene editing based therapy. Despite promise in this
area, turning the system against its bacterial origins is a significant opportunity for
pathogen control and microbiome manipulation 62,63. Because many bacteria
already contain active CRISPR-Cas machinery, one can either harness this native
system or express a heterologous system to enact the desired genome
modifications. Each method comes with its own strengths and weaknesses,
prompting a question of rational design depending on the desired application. This
section will first focus on techniques for harnessing endogenous machinery before
turning its attention to the heterologous approach.
The ability to harness native CRISPR-Cas systems for modification of the
host’s genome presents a different set of variables than heterologous eukaryotic
manipulation. First, the expression of CRISPR-Cas systems is subject to
environmental conditions and cellular stress responses, in particular the presence
of foreign species and phages64. While this can be detrimental in some cases, this
enacts a degree of control that may be desirable, particularly when dealing with
modulating species within a population. In fact, the ability to control expression of
certain genes with CRISPR-Cas mediated interference has been shown to be a
natural phenomenon62,65. Multiple species’ native CRISPR-Cas systems have
been utilized for editing and gene knockdown via the introduction of self-targeting
guides, notably Pseudomonas aeruginosa (Type I)66, Escherichia coli (Type I)65,
Clostridium pasteuranium (Type I)67, Staphyloccous aureus (Type II, Type III)68. In
particular, due to the hyperactive nature of CRISPR-Cas in multidrug resistant P.
aeruginosa, its system was turned against the mexB gene (efflux pump
component) successfully re-sensitizing the strain to antibiotics69. Use of the native
machinery in C. pasteuranium was also compared to the heterologous approach
and shown to be significantly more efficient than use of a heterologous Cas9.
While these reports highlight the potential of the endogenous approach, working
in a new organism requires careful characterization of the endogenous machinery
(e.g., PAM identification) to ensure proper targeting70. In contrast, the heterologous
approach utilizes a well-characterized Cas system that has the potential to be
rapidly deployed to a larger number of organisms, specifically eukaryotes as they
contain no native CRISPR systems.
Heterologous expression and activity of CRISPR-Cas single-effector
nucleases has shown to be surprisingly robust across a wide variety of hundreds
of organisms14,71. Paradoxically, the domains exhibiting the greatest difficulty with
heterologous Cas expression are those of bacteria and archaea. This is due to
two factors: 1) the global cellular response to DNA DSBs and 2) the broad native
defense systems (including native CRISPR-Cas) that inhibit foreign DNA
uptake72,73. These barriers will be crucial to address when deploying CRISPR-Cas
6

in bacteria. Due to the DSB toxic response, many research endeavors into
CRISPR-Cas in bacteria usually employs catalytically inactivated enzymes for
gene knockdown13. Targeting genes with dCas9 has created a robust technique
to screen genes for essentiality that are helpful in the identification of putative drug
targets74. However, the use of CRISPR itself as an antimicrobial is promising, due
to the tuning of the system to a unique sequence, and therefore unique sequence,
limiting the undesirable targeting of commensurate species in a host or
environmental microbiome75. However, many improvements must be made to
CRISPR-Cas efficiency and delivery for such a system to be deployed in real-world
applications62,63,76.
Bacterial Responses to CRISPR-Cas
Evolution dictates the survival of a population over that of an individual cell,
meaning that cellular adaptation and sacrifice is a means of preventing potentially
harmful genetic elements (including self-targeting CRISPR-Cas machinery) from
making their way through a population. The SOS response of bacterial is a highly
regulated system that is induced by a variety of environmental factors. Briefly,
LexA (repressor) and RecA (inducer) act as a control gate for the expression of
downstream genes whose products are responsible for error-prone repair of a
damaged DNA region73. In many bacteria, RecA governs a strong homologous
recombination pathway that is highly favored due to the fact that rapidly dividing
bacteria may harness up to 10 copies of its genome in a single cytoplasm. Further
downstream, the error-prone polymerases (polB, dinB, umuC, umuD) are
increasingly upregulated the greater the amount of DNA damage present. This
genetic coordination can potentially have several advantages. First, it serves as
an adaptive mechanism, allowing the induction of the SOS response to create
mutations that could potentially serve as beneficial to the new environment 72.
Second, it also provides a means of mutating away from highly active CRISPRCas expression. Specifically, the greater number of breaks induced can increase
the likelihood that an error-prone polymerase repairs the break by introducing
mismatches, thereby rendering the expressed guide-RNA inactive. Therefore,
managing the SOS response is key to achieving high levels of CRISPR-Cas
activity. Inhibition of the activating RecA demonstrates this principle and is a key
insight for designing CRISPR-Cas antimicrobials73. Future studies can be directed
at such SOS response co-targeting to investigate the chokepoints that enable high
CRISPR-Cas toxicity.
Not all bacteria exhibit an SOS response. In particular, the well-known
pathogens Campylobacter jejuni, Streptococcus pneumoniea, Streptococcus
pyogenes, Legionella pneumophila, Helicobacter pylori, Neisseriae meningititis,
and Neisseriae gonorherae all lack an SOS response system72. These species
are hypothesized to make up for this seeming lack of repair pathway by
upregulating their competence mechanisms, taking in foreign DNA as a means of
adaptation. Further, other pathways loosely regulated by SOS exist in many
bacteria and archaea, namely primitive non-homologous end-joining (NHEJ) and
7

microhomology end-joining (EJ) proteins that can repair DNA double strand breaks
in low quantities28,77. These two mechanisms can also serve to adapt away from
self-targeting CRISPR-Cas13. Bacteria also co-opt valuable elements from their
infecting phages. Relevant to the study of DNA repair is that of the highly active
ligases that can efficiently repair DSBs77. These may induce mutations at the site
of the break, preventing further targeting.
The diversity of DNA repair pathways throughout the bacteria and archaea
kingdoms suggest that increasing CRISPR-Cas antibacterial potency can be
achieved by weakening host defense systems but the choice is highly speciesand environment-dependent. Even those species without an SOS response are
sensitive to the stress associated with introducing exogenous CRISPR-Cas
machinery, whether it be through plasmid delivery via transformation or
conjugation, or through phage RNA/DNA delivery. This makes targeting the
defensive machinery all the more crucial for designing efficient CRISPR-Cas
antimicrobials.
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CHAPTER TWO
IDENTIFICATION AND QUANTIFICATION OF CRISPR-CAS
TARGETS
Summary: A version of this chapter was originally published by Brian Mendoza and
Cong T. Trinh titled: “Enhanced guide-RNA design and targeting analysis for
precise genome editing of single and consortia of industrially relevant and nonmodel organisms.”43

Introduction
Transforming biology into engineering practice has shaped the frontiers of
synthetic biology and metabolic engineering 78,79. This helps drive industrialization
of biology with broad applications related to food, health, energy, and the
environment from production of drugs to fight diseases to synthesis of renewable
fuels to replace fossil fuels 80. Genetic diversity of non-model organisms offers a
repertoire of unique phenotypic features for exploration and cultivation for these
applications 81,82. To realize this enormous potential, it is critical to have an efficient
genome editing tool for rapid strain engineering of these organisms to perform
novel programmed functions. In the last several years, the CRISPR technology
has emerged as a powerful genome editing tool for metabolic engineering and
synthetic biology applications 9,13,48,83-91.
Using a CRISPR/Cas system for genome editing requires it to be both highly
active and accurate. CRISPR tools that are used to design guide-RNAs (gRNAs)
to form ribonucleoprotein (RNP) complexes for effective genome targeting focus
on two types of evaluation. The first type is the prediction of “on-target” activity of
a selected gRNA on a target DNA (or RNA) sequence on the genome. This ontarget activity reflects the ability of such a gRNA to successfully find and bind the
Cas endonuclease to the target sequence. The second type is the prediction of
“off-target” activity of a selected gRNA, which pertains to the propensity of the RNP
complex to interact with sequences on the genome similar to the target sequence.
Choosing gRNA sequences with high activity is paramount to all genome editing
endeavors for metabolic engineering and synthetic biology applications 57,92,93. To
predict which sequences lend themselves to efficient targeting, various algorithms
have been developed based on high-throughput experimentation and validation
29,30,94. By identifying prominent nucleotide features in highly active gRNAs and
their target sequences, scoring tables were generated and a gRNA sequence may
be cross-referenced to predict its on-target activity. Past experimental evidence
has revealed that the CRISPR RNP complex can reach cleavage efficiencies of at
least 80% for single site modification 83. However, this efficiency might become
problematic when applying a CRISPR/Cas system to modify multiple sites across
the genome simultaneously using multiple gRNAs, known as multiplexing, for rapid
strain engineering. For instance, the probability of achieving activity at 5 loci
simultaneously drops to 32% (0.85). Therefore, developing new algorithms
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capable of accurately designing gRNA sequences with high activity is important
for multiplex CRISPR implementation.
In addition to the on-target analysis, it is very critical to make sure that a
gRNA design has limited activity at non-targeted sites. The foundation for such offtarget analysis for the spCas9 (Cas9 derived from Streptococcus pyogenes)
system in eukaryotes was established by Hsu et al. 95 and later by Lin et al. 96.
Studies building on this foundation generally take two directions: one being the
engineering or discovery of alternative Cas enzymes that exhibit lower off-target
activity 97, and the other being algorithms that enhance prediction capabilities 96.
Recently developed software platforms have implemented various algorithms to
determine off-target sites for a gRNA design, based on either biological principles
or training a model to fit experimental data 30,34,98,99. A collection of these programs
is detailed at https://omictools.com/crispr-cas9-category. Unfortunately, some
potential off-target sequences are unable to be reconciled by these algorithms that
do not account for newly discovered interactions between the target DNA and
RNP. For instance, a study by Malina et al. shows the presence of PAMs
(Protospacer Adjacent Motifs) across the sequence to be inhibitory to Cas9
cleavage 100. This underscores the need for additional experimental investigations
into off-target effects and a robust algorithm to capture these effects for designing
gRNAs, especially when applying CRISPR/Cas systems to non-model organisms.
Furthermore, the rapid discovery of novel, diverse Cas enzymes beyond
spCas9 requires a flexible and robust algorithm that can accurately predict on- and
off-target activities utilizing new CRISPR/Cas systems for genome editing. For
instance, the discovery and use of another type of CRISPR class II endonuclease,
Acidaminococcus sp. Cpf1 (asCpf1), has shown complementary activity to the
Cas9 family with a T-rich PAM and “sticky-end” generation 25. Based on the crystal
structure of the asCpf1-RNA-DNA heterotriplex, it is possible to infer important
nucleotides within the CRISPR-RNA (crRNA) for catalytic efficiency, and thus
develop accurate targeting algorithms for genome editing 24,34.
While previous research has focused on identifying highly active and unique
target sites using on- and off-target algorithms to assist in gRNA design, targeting
non-unique (repeated) sites with CRISPR tools may lead to some interesting future
directions for experimentation 101. This strategy, called multitargeting, has powerful
metabolic engineering and synthetic biology applications, but has not yet been fully
explored. For instance, repeated sequences may serve as sites where a single
gRNA could induce knockouts across multiple orthologs of a gene, reducing the
amount of heterologous machinery required to achieve the same effect.
Furthermore, engineering consortia of organisms has been a burgeoning field in
the past decade 102. CRISPR tools can potentially investigate and modify these
consortia, which may not be achievable by conventional genetic manipulations.
Software with the ability to implement these applications can pave the way for
novel metabolic engineering and synthetic biology applications using CRISPR/Cas
systems.
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In this study, we developed a novel method, named CASPER (CRISPR
associated software for pathway engineering and research) that implemented
flexible algorithms to guide precise genome editing. Combining both experimental
data and newly discovered biological principles, CASPER formulated an improved
scoring method for enhanced prediction of on- and off-target activities. This
prediction presents “relative” activities of a gRNA design that depend solely on
target sequences, and hence are independent of experimental conditions (e.g.,
growth rate, Cas9 concentrations, and DNA supercoiling). These “relative”
activities are different from “absolute” activities of a gRNA design that are
condition-specific and must be determined experimentally 87,95. Further, CASPER
expanded novel applications of CRISPR/Cas systems in genome editing including
multitargeting analysis (i.e. simultaneous multiple-site modification on a target
genome with single gRNA requirement) and multipopulation analysis (i.e. gRNA
design for genome editing of a consortium of organisms).

Methods
On-target activity formulation for CRISPR gRNA design
On-target activity is defined as the binding affinity and subsequent nuclease
activity of a particular gRNA and endonuclease complex to its matching DNA (or
RNA) target sequence. Such activity depends on many factors that have been
identified such as the state of DNA supercoils, genome size, Cas endonuclease
concentration, and growth rate 87. These variables change based on the organism
and the experimental conditions and thus make it impractical to integrate into an
algorithm designed for assessing a large set of non-model organisms and
alternative Cas endonucleases. Such factors have the same effect on every target
within a genome and therefore have no impact on the difference in relative activity
between targets found on the same genome.
To predict the on-target activity of the complex, our developed CASPER
method calculates the score SC,P (Equation 2.1) that is defined as follows:
Equation 2.1

SC ,P =

SC
P

where SC is the CRISPRscan 94 score and P is the penalty score. In Equation 2.1,
SC,P has a value between 0-100 that is assigned to a gRNA seed sequence, with
higher values indicating higher predicted activity. The CRISPRscan score S C
(Equation 2.2) is defined as follows:

11

Equation 2.2
l+6

åS

SC,P =

C ,i

i=l-6

where l is the length of a seed sequence and PAM (see Figure 8 for indexing
illustration), and SC,I, is the score associated with the mono and dinucleotide
features at position I (Ni or NNi) of the seed sequence that has been experimentally
determined to be relevant 94. Each score, SC,I, is the sum of the values of the
features appearing at position I, and the sum of all positions’ scores (SC) is
normalized with respect to the highest and lowest possible scores to obtain a
normalized value from 0 to 100. The values of features at any given position can
be seen in the CRISPRscan scoring table31.
The penalty score, P, (Equation 2.3) is obtained by the combination of the
PAM density score, sij, (Figure 9) and the score SG (Equation 2.4):
Equation 2.3

ì sS
sij > 1
ï
ij G
P=í
ïî 1- SG / 5 sij = 1
The score sij in Equation 2.3 is determined by the number of PAMs present in a
given seed sequence, where i is the number of PAMs in the forward sequence and
j is the number of PAMs in the reverse complement of the sequence. The score s ij
can be looked up in the ith column of the jth row in Figure 9, which is derived from
experimental data 100. Due to the length of the spCas9 PAM (3) and the length of
a seed sequence (20), i + j < 8. In Equation 2.3, the score SG, used to reinforce
the importance of guanines and adenines to the stability/instability of the gRNA
respectively, is formulated to account for the nucleotide composition of the seed
sequence irrespective of position.
Equation 2.4

SG =

l-PAM

å

ni

i=1

ì 1
ï
ni = í 0.5
ï -0.1
î

if

Ni = G

if

Ni = C

if

Ni = A

The values ni were derived to maximize correlation between scores and on-target
experimental data 94 further described in the Results. A visual summary of the
process of obtaining an on-target score for a sequence is shown in Figure 8.
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Off-target formulation for gRNA design
In contrast to the on-target activity assessment, the off-target activity is defined as
the probability of a given gRNA sequence to interact with a non-matching
sequence on the genome. Our developed CASPER method calculates the offtarget score SH,T,S as follows:
Equation 2.5

S H ,T ,S

(
=

)

S H + ST R2 S S6
4

where the off-target score SH,T,S lies between 0 and 1, with a higher value indicating
higher probability of off-target activity, and is determined by combining four
subscores SH, ST, SS, and R discussed below. The appropriate arrangement of
these scores in Equation 2.5 was determined by employing a genetic algorithm
using the Pearson’s coefficient between the output scores and experimental
cleavage efficiency 95 as the fitness function. A more detailed description of the
algorithm is presented in the Results. The subscore S H accounts for the types of
nucleotide mismatches and their location on the seed sequence, and is defined as
follows:
Equation 2.6
20

S H = Õ M ij
i=1

where Mij is the element of the Hsu matrix derived from experimental data gathered
in Hsu et al. 95 represents the index of the mismatch, and j corresponds to the
identity of the mismatch (e.g. C with A).
The subscore ST is derived from the inverse relationship of the proximity of
the mismatch to the PAM:
Equation 2.7
20

ST =

3.5477 - å

1
i=1 i
3.5477

where ST is valued from 0 to 1 with a higher score indicating a higher probability of
off-target activity, and i is the index of the mismatch. This score was motivated by
previous studies showing the farther a mismatch is from the PAM site, the less
likely it is to interfere with activity 49. As a result, sequences with PAM distal
mismatches are more likely to be sites of off-target activity. Summing the values
for a mismatch at every location across the seed sequence gives a value of 3.5477,
thus this number is used to normalize ST as formulated in Equation 2.7.
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The subscore SS also captures an inverse relationship of the proximity of
the mismatch to the PAM but is formulated using a stepped scale:
Equation 2.8

ì 0.1
i£6
SS = 1- ai ai = ïí 0.05 6 < i £ 12
i=1
ï 0.0125
i > 12
î
where i is the index of the mismatch, and a i is defined by a step function. The step
sizes were derived to agree with the previous experimental report where
mismatches in regions closer to the PAM are more detrimental to activity 95.
Using the knowledge that some gRNAs are more stable/active than others,
the on-target activity scores of the target sequence and the off-target sequence
are assembled into a ratio, R:
20

å

Equation 2.9

R=

SCoff,P
SCon,P

where SC,Poff and SC,Pon in Equation 2.9 are the on-target scores for the target DNA
sequences appearing at the undesirable and desirable sites of the genome,
respectively. A ratio of R < 1 signifies that the sequence of interest (SOI) is more
active compared to the potential off-target site, meaning less likelihood of the offtarget site being hit compared to the SOI. A ratio R > 1 signifies the reverse, i.e. a
highly active off-target site that has an increased likelihood of being hit compared
to the SOI. The visual representation of gathering all these scores and combining
them for a given two sequence comparison can be seen in Figure 8.
Multitargeting analysis
Multitargeting is the process of editing multiple sites simultaneously across the
genome of an organism using a single gRNA. Instead of removing repeated gRNA
target sequences, our developed CASPER method stores the data of repeated
sequences for further analysis. To generate data of the non-unique seed
sequences, CASPER references the set of sequences that appear more than once
to
a
genome
annotation
file
generated
by
either
GenBank
(http://www.ncbi.nlm.nih.gov/genbank/) or KEGG (genome.jp/kegg/). These
sequences are then sorted based on the number of times they appear in an
annotated region. Further analysis can be performed by investigating individual
sequences in order to design gRNAs to target these repeated sequences.
Multipopulation analysis
To analyze multiple genomes simultaneously for use in the study and genetic
modification of a consortium, CASPER collects the data by identifying targets
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across a collection of genomes and performs on- and off-target activity analysis
against the entire metagenome. This enables precise gRNA design for accurate
genome editing within a consortium. To deal with polyploid organisms, the same
algorithm can apply. Sequences shared across genomes can also be identified,
thereby applying the concept of multitargeting to populations.

Results and Discussion
Development of CASPER algorithm for enhanced on-target activity
prediction
In order to analyze sequences to be targeted by a gRNA/Cas complex, we
developed an algorithm for CASPER to predict the gRNA design for the on-target
activity (Equation 2.1). It was formulated to incorporate three guiding principles: i)
the CRISPRscan features experimentally identified to be present in highly active
guide sequences 94, ii) the density of the PAM in question across the guide
sequence 100, and iii) the propensity for guanines (and to a lesser extent cytosines)
over adenines in the gRNA sequence which has been shown to be a factor in
gRNA stability 29,103. To formulate a combination of these three principles, we
combined the normalized CRISPRscan score, SC (Equation 2.2) and divided it by
a penalty score, P (Equation 2.3). The structure of P is determined by whether or
not the number of PAMs in the sequence is inhibitory (s ij > 1). If so, the value is
multiplied by the score SG; otherwise, it is disregarded, and P purely accounts for
the nucleotide content of the sequence (the SG score). While the values of sij are
derived directly from experimental data 100, the score SG needs to be constructed
de novo.
Since previous studies showed guanines were favorable and adenines
unfavorable to gRNA stability 29,103, we decided to value guanine most favorably
(positive value) and adenine least favorably (negative value). The values assigned
to guanine, adenine, and cytosine (Equation 2.4b) were obtained by varying their
values between 0 to 1 (with a step of 0.1) and then evaluating which combination
of values resulted in the optimal Pearson coefficient between experimental data
from Moreno-Mateos et al. 94 and the score, SC,P.
We applied CASPER’s on-target activity algorithm to predict the on-target
activities of gRNAs from the experimental study by Moreno- Mateos et al. 94. This
study investigated indel frequency from a pool of 1280 gRNAs in zebrafish single
cell embryos at 9-hour post fertilization. The CASPER method provided a minor
2.4% improvement in the R2 value as compared to the CRISPRscan model (Figure
3A) by taking into account PAM density and position-independent nucleotide
content. Such a minor variation underscores the robustness of the CRISPRscan
model. This improvement is statistically insignificant from the CRISPRscan model
as determined by an F-test between the two data sets (α = 0.05). However,
CASPER successfully identified 3 out of the 4 largest CRISPRscan score outliers
in an experimental dataset of 25 gRNAs (Figure 3A).
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CASPER’s on-target activity algorithm can be refined with subsequent data
sets or further studies on spCas9’s underlying mechanism of action. Additional
on-target data sets generated by future studies will allow CASPER to develop
parameters to assess gRNA activity in novel CRISPR/Cas systems (i.e. diverse
organisms and Cas enzymes). For instance, CASPER’s on-target activity
algorithm can be applied directly to asCpf1 as soon as experimental data of ontarget activity becomes available. In the meantime, to evaluate asCpf1 and other
non-canonical endonucleases, CASPER focuses on the principles governing PAM
density and guanine/adenine content to predict on-target activity.
Development of CASPER algorithm for enhanced off-target activity
prediction
The objective of off-target analysis is to determine the sequences most
likely to exhibit activity despite not being an identical match to the de-signed gRNA.
Many factors contribute to off-target activity, including the number and location of
mismatches, the number of times the PAM appears across the genome, and the
concentration of the endonuclease. Only those variables relating to sequence
identity are considered here, as other factors are considered to be either relatively
constant (e.g. Cas9 concentration) or entirely unpredictable (e.g. state of DNA
supercoils) when comparing one sequence relative to another. To per-form such
an analysis, an algorithm was developed for CASPER to compare all potential
target sites in the genome to the SOI. For each comparison, mismatches between
the two sequences are identified. If the total number of mismatches across the two
sequences exceeds 4 the pairing is given a score of 0, signifying there should be
no appreciable activity at the off-target sequence in question. The mismatches are
then scored according to Equations 2.6, 7, and 8a. In addition, the on-target scores
for the two sequences are obtained and the ratio (Equation 2.9) is also
incorporated into a final score, SH,T,S (Equation 2.5). This scoring method improved
prediction capabilities by 30.2% in the R2 value (Figure 3B) over the canonical
study36.
The enhanced correlation to experimental values could be attributed to the
combination of incorporating experimental data (subscore S H)36 and guiding
principles derived from the CRISPR RNP complex’s mechanisms of action
(subscores ST, SS, R). A genetic algorithm was employed to determine the
optimum arrangement of the subscores (SH, ST, SS, and R) to create a single final
score, SH,T,S, and to determine if any subscore was redundant. The result from the
combinations of these scores were compared to experimental values given in Hsu
et al. and the resulting correlation (R 2) was used as the fitness parameter for the
genetic algorithm. The algorithm was given free range over modifying the
coefficients and exponents for each of the subscores, as well as the general form
of the equation, i.e. whether the subscores were added/subtracted or
multiplied/divided to each other. The algorithm was initialized with 100 possibilities
and the fittest “parents” were chosen for crossover to create a new generation.
Each generation spawned 100 children. By running the algorithm for 1,000
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generations, the final format present in Equation 2.5 was achieved. To confirm the
algorithm was not over trained on the experimental data set provided, a separate
set of data36 was used for determining the correlation of the algorithm’s output with
experimental off-target activity data (Figure 3B).
Off-target guiding design principles of asCpf1 are similar to those of Cas9
in that the PAM proximal nucleotides are important for binding and enzyme activity,
particularly the first 825. Due to the lack of off-target experimental data at the time
of this study, asCpf1 off-target identification was simplified to the use of equations
7-9 as off-target data to generate a matrix for Equation 2.6. In addition, using the
recently solved crystal structure of the asCpf1-RNA-DNA heterotriplex24 enables
us to exclude the 4 most PAM distal nucleotides of the 24-nucleotide gRNA
sequence, as they are oriented away from pairing with the DNA when complexed
with asCpf1. The parameters of Equation 2.8 were modified to give Equation 2.10:
Equation 2.10
24

SS = 1- å ai
i=1

ì 0.1
ï
ai = í 0.0125
ï
0
î

i£8
8 < i £ 20
i > 20

As in Equation 2.8b, the values for ai in 2.10b are calculated such that a
completely mismatched sequence is given a score (SS) of 0. This equation
accounts for experimental observations that the most significant nucleotides in the
seed sequence for asCpf1 are the 8 nucleotides proximal to the PAM. In the
absence of experimental data, to perform off-target activity analysis on noncanonical CRISPR endonucleases, such as asCpf1, CASPER subscores can be
used independently to evaluate off-target activities. The 30.2% increase in R2
value was evaluated for statistical significance by an F-test using the scores from
the Hsu matrix. It was confirmed that the CASPER algorithm represents a
statistically significant improvement (p < 0.05).
The newly developed CASPER off-target algorithm can be quickly adapted
to other systems seamlessly by training the algorithm against a set of experimental
data and accounting for observed features associated with the biophysical
properties of the CRISPR RNP complex. CASPER therefore provides a foundation
for establishing in silico off-target analysis for a variety of organism and
endonuclease combinations, especially when dealing with non-model organisms.
Development multitargeting analysis
While sequences repeated in a genome have been traditionally discarded due to
their inherent lack of specificity, we developed CASPER to exploit these
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sequences as potential gRNAs that are capable of targeting multiple sites across
a genome with useful applications in synthetic biology and metabolic engineering.
To demonstrate CASPER for multitargeting analysis, we compiled data for
34 genomes of model and non-model organisms with three different
endonucleases (spCas9, asCpf1, and spCas9-VRER) to gain perspective on the
number of target sites that appear across each genome (Figure 4). Genomes with
a low GC content such as Clostridium beijerinckii (31.0%) and C.
saccharobutylicum (29.4%) have a much greater number of target sites for asCpf1
(PAM: TTTN) than that of spCas9 (PAM: NGG). The spCas9-VRER variant (PAM:
NGCG) in particular have only a couple thousand sequences appear for the
mentioned organisms, a two order of magnitude difference compared to asCpf1.
In addition, the greater PAM length of the VRER variant, which one would assume
to appear less frequently than the canonical NGG, does indeed present less target
sites across all the organisms investigated. These results show that some
endonucleases are more useful than others depending on the genome and
application. While this paper only presents a representative sample of non-model
organisms, the algorithm is capable of analyzing any desired combination of
organisms and endonucleases.
To understand where these repeated sequences appear, we mapped their
locations on the annotated genomes. Figure 5 reveals that many of these
sequences appeared in annotated regions, but a significant number also fell in
unannotated ones, particularly sequences targeted by asCpf1 as shown by the
significant number and height of black bars in Figure 5B, 5D. This discovery is
valuable in that it helps reveal regions of the genome that may be related and
subsequently probed through the precise CRISPR genome editing tool. Further
analysis into non-unique targets in unannotated regions revealed a significant
number of sequences in regions of completely unknown function. Sequences
appearing in unannotated regions are particularly useful for two reasons. First,
designing gRNAs to target sequences that appear in unannotated regions may
reveal information about whether these regions are functional. Second, these
sequences can be used for inserting multiple copies of genetic cargo with a
reduced risk of unintentional disruption of cellular function. With multitargeting
analysis, CASPER facilitates the investigation and manipulation of unannotated
regions with the CRISPR/Cas system for rapid genome editing.
To discover cellular processes that lend themselves to multitargeting, we
looked further into the identity of the annotated regions in which these sequences
were appearing. A cursory examination of the repeated sequences across the
genomes revealed that transposable elements appear frequently across all
organisms and can provide a powerful platform for integration of multiple copies of
genes or entire operons (Figure 6). Across the species investigated, between half
and two-thirds of the non-unique sequences found on annotated regions were
located on a transposon related feature. The promise of harnessing transposons
for genome manipulation has been well documented by the utility of the Sleeping
Beauty transposon system (e.g. SB10) 104,105. In addition to transposable
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elements, regions labeled as hypothetical proteins are also common sites to find
repeated sequences (Figure 6). Targets within hypothetical protein regions may
be useful in a similar manner to those appearing in unannotated regions because
the function of these cryptic regions can be systematically investigated.
Of particular interest are also the repeated sequences that appear on gene
loci. Figure 6 details the common motifs targeted by non-unique sequences across
the genomes of C. thermocellum, C. aceticum, and C. kluyveri. Interestingly,
elements such as the cellulosome anchoring protein of C. thermocellum, a defining
feature of the organism, is targeted 197 times by repeated sequences, opening the
possibility of interrogating this structure with a select number of gRNAs. In S.
cerevisiae, hexose transporters (416 times) and heat-shock proteins (111 times)
are cellular processes that also may be targeted simultaneously by a single gRNA
and are of particular interest for metabolic engineers looking to probe the sugar
metabolism and environmental sensitivity and adaptation in this organism. In
general, CASPER is capable of performing multitargeting analysis in any organism
and with any endonuclease desired.
Development multipopulation analysis
When editing a consortium of organisms with a CRISPR/Cas system, one must be
mindful of the existence of similar or even shared sequences among genomes.
Horizontal gene transfer of a plasmid containing the CRISPR/Cas system can
exhibit activity in other species’ genomes within a consortium. Additionally, direct
transformation of the RNP into a consortium may result in unintended off-target
activity in multiple species. It is therefore important to screen all genomes in a
consortium for potential off-targets. We have developed the CASPER off-target
algorithm to check for off-target sites across genomes in the consortium, thus
minimizing unintended activity not just within the targeted organism but the
consortium as a whole. In addition, CASPER can identify repeated sequences
across the genomes that may lend themselves to multitargeting. This enables the
identification of potential sites where multiple organisms in the consortium can be
edited with the same gRNA.
To examine more closely the opportunities for multitargeting in a
consortium, we ran CASPER against pairs of Clostridial species. Figure 7A-B
details the number of sequences available for such targeting between the pairing
of C. thermocellum and a selection of thermophilic species, as well as the pairing
of C. cellulolyticum with other mesophiles. Additionally, CASPER is capable of
performing an analysis on multiple organisms to identify repeated sequences
shared across them. For instance, we applied CASPER to identify repeated sites
across C. kluyveri, C. cellulolyticum, and C. aceticum (Figure 7C-D). This
consortium was designed to utilize either biomass or a hydrogen/carbon dioxide
feed for production of industrially relevant long-chain organic acids. This example
demonstrates how CASPER can be used to identify off-targets and multitargeting
analysis for genome editing of a consortium.
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The number of sequences that may be used to target multiple organisms is
quite small when compared to the size of the genomes. Thus, we postulate that
the usefulness of multitargeting across organisms lies in niche insertions or
deletions, such as those targeting a gene with high sequence similarity across the
organisms in question. The opportunities for such manipulation will vary drastically
depending on the identity of a consortium. Further, off-target analysis for a
consortium will prove crucial in preventing unintended activity. Overall, CASPER’s
algorithms can facilitate the use of CRISPR tools to edit target genomes within a
heterogeneous consortium.
The multipopulation analysis framework can also be utilized to analyze
polyploid organisms. If individual allele sequences are known, they can be
uploaded as separate ‘genomes’ and then compared via multitargeting on- and/or
off-target analyses. This enables the selection of target sequences both unique
and shared amongst alleles, facilitating partial or complete allelic editing with
CRISPR/Cas.

Conclusion
The development of CASPER’s flexible algorithms for analyzing on- and off-target
activity in any organism with any Cas enzyme broadens the utility of CRISPR tools
for genome editing of industrially relevant and non-model organisms. CASPER’s
multitargeting analysis facilitates simultaneous genetic manipulation of multiple
loci using a single gRNA with novel potential applications including the
investigation of large complex systems (e.g. the cellulosome of C. thermocellum)
and unannotated genome regions. Further, CASPER’s multipopulation analysis
provides the ability to investigate microbial consortia and apply the CRISPR tools
to perform genetic manipulations on single or multiple organisms within the
consortia. We envision CASPER will assist the progress of CRISPR genome
editing for metabolic engineering and synthetic biology applications.
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CHAPTER THREE
A CRYSTAL STRUCTURE ENERGY CALCULATION ENSEMBLE
FOR PREDICTING OFF-TARGET ACTIVITY OF SINGLEEFFECTOR CAS NUCLEASES
Summary: Understanding the specificity of CRISPR-Cas systems is critical for
advancing the technology as a safe genome editing technology. In order to
reconcile wide-ranging results of experimental studies attempting to measure onand off-target activity, this study employs a computational approach using the
protein modeling software suite, Rosetta, to create a transition-state-like model
that can approximate the thermodynamic and kinetic contributions (collectively
coined relative activity) to the protein-RNA-DNA heterotriplex of multiple singleeffector Cas nucleases. The resulting score parameter of this simulation outcompetes the best performing convolutional neural networks with a Spearman
correlation of 0.5 and a best-in-class AUC (area-under-curve) from a relativistic
operating curve (ROC) of 0.860. This work represents the first full ternary (RNP,
DNA) complex modeling for CRISPR-Cas activity, and the most comprehensive
attempt to account for all sources of the relative thermodynamic activity. We
hypothesize large deviations between computational results and experimental
data are likely the result of experimental conditions and DNA target superstructure
in vivo (coined absolute activity). To elucidate this absolute activity, we used
experimental data using a Cas12 dataset35 with degenerate guide sequences
(multitargeting) to assist in labeling genomic sites as amenable or inhibitory to
targeting.

Introduction
The power of CRISPR-Cas (Clustered Regularly Interspaced Palindromic
Repeats, CRISPR Associated) as a genome editing platform is reflected in its
ubiquity in biological research. Despite the promises (and fears) of a panacea of
cures for cancer, super-crops, and embryonic manipulation, the biochemistry of
the native CRISPR-Cas proteins exhibit certain degrees of non-specific activity,
which is a major concern especially when considering engineering heritable
modifications1,36,48. This “off-target” activity is a priority for those looking to
commercialize CRISPR-Cas technologies for applications sensitive to non-specific
changes in the genome. To better understand the underlying mechanisms of
CRISPR-Cas enzymatic activity, a combination of single molecule mechanistic
studies39,106-108 and large library assays both in vitro and in vivo have been
performed36. Single molecule crystallography and FRET analysis have illuminated
kinetic factors important to Cas enzyme recognition, binding, and ultimately
cleavage using spCas939,107. These studies have identified the formation of the Rloop (DNA unwinding and RNA binding) as the thermodynamic barrier to Cas
protein binding and cleavage. This principle has then been expanded upon in
theoretical studies to identify correlation of a parametrized R-loop model to
experimental cleavage assays investigating off-target activity37,47. Large library
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assays have taken a broader view, looking at RNA/DNA sequences for insight into
active guide-RNAs for future application30,32. These studies provide the foundation
for a large number of predictive algorithms based on either first principles from
mechanistic insight87, machine learning from the generated datasets29,31,36,109, or
combinations of the two43,49,50.
Recently, deep learning methods with neural networks have become
popular in predicting on- and off-target activity in datasets45,110. While the ability
for newer models to avoid false positives in a variety of datasets is promising, the
unexplainable nature of these algorithms is currently a detriment to the
advancement of better designed guides at the outset. Further, the need for
comprehensive datasets with strong control for environmental, condition-specific
variables can create variability in the predictive capability of deep-learning
algorithms across datasets and Cas enzymes.
Macro trends can be observed in both experimental and computational
studies, however, the field is riddled with conflicting information that has led to
controversy. Particularly, reports have come out in close succession suggesting
either a lack of or ubiquity of off-target activity, creating confusion as to the exact
nature of the fidelity of Cas enzymes34,35,55,97. At the center of the apparent
contradiction is the difficulty of separating relative from absolute activity. As
previously defined43, relative activity refers to the thermodynamics and kinetics
associated with the Cas endonuclease, its guide-RNA and immediate DNA target.
This information is known at the outset of experimental design and is the common
form of input for generation of correlation functions, including machine learning
exercises. The more complicated absolute activity refers to the entirety of factors
influencing Cas activity including both controllable experimental factors and
elements that are difficult to quantify, but not limited to: DNA supercoiling, DNA
chromatin structure, transcription factor binding competition, polymerase binding,
and DNA repair machinery protections. Recently, some of these factors (DNA
supercoiling and chromatin structure) have been proven to play a key role in the
kinetics of Cas enzymatic activity, while others have been known but their role
relatively hard to quantify (DNA repair pathways) 37,42,111-113. Due to the extreme
variability in absolute activity, the model proposed in this work focuses on
developing the most accurate assessment of relative activity that can be used
irrespective of factors influencing absolute off-target activity. Often, the absolute
activity factors can be parametrized during the design phase (e.g., titration of Cas9
concentration) that can maximize efficacy while minimizing off-target activity. The
ability therefore to have an explainable model that accounts for all relative activity
is incredibly helpful for informing the design of effective guides. In turn this
information can be used to understand the state of activity across different genomic
loci, as absolute activity is reintroduced into the equation, while relative activity is
controlled for by the in silico model.
Use of computational tools to identify thermodynamic and kinetic
parameters of protein interactions is widely used but suffers diminishing returns as
the size of the protein and intensity of the simulation is taken into account. For
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instance, molecular dynamics simulations (MD) are state-of-the-art for
interrogating atomic-level interactions, but are so computationally intense they can
only perform simulations up to the millisecond timescale on relatively small
proteins (<30kDa) and peptides114,115. The Rosetta operating environment was
developed in order to perform ab initio protein folding simulations to predict the
most likely structure116. Briefly, it simplifies protein structures into degrees of
freedom (e.g. rigid body rotation/translation) and employs physical scoring
functions based on the positions of atoms in a Cartesian space. This framework
is coupled with a Monte Carlo Minimization to sample conformational states with
the lowest-energy state as an approximation for the native state of the structure.
The substantial reduction in calculation time from MD simulations enables Rosetta
to be performed on a greater number of larger structures. This study seeks to
employ this modeling strategy for the investigation of a large number of DNA-RNACas protein heterotriplex structures to identify the thermodynamic contributions of
the entire complex and its correlation to on- and off-target activity.

Methods
Structure preparation
The starting Protein Data Bank (PDB) structures of Cas enzymes complexed with
RNA and DNA molecules were first downloaded from RCSB. In the case of the
Cas12 structures, before the 20-structure ensemble could be generated (Figure
10, the RNA and DNA molecules were extended with the DNA/RNA builder in MoE
(Molecular Operating Environment, Chemical Computing Group) to the
appropriate lengths used in the experimental studies (25 and 24 respectively). In
order to create the mutant structures (Figure 10), the PDB structure was separated
into its component chains. Nucleic acid chains were mutated with the
rna.thread.default Rosetta algorithm developed by the Das Lab 117. The PDB
structures were then recombined with their respective chains and heteroatoms
(e.g. Mg, Ca, H2O). The recombined PDBs were in the case of the on-target
structures relaxed then minimized, or just minimized in the case of off-target
structures. Truncated structures were generated by removing residues from the
minimized structures and then generating a new Pose score for the structure using
the scoring algorithm. As Rosetta tags heteroatoms to the first residue by default,
the flag “-in:auto_setup_metals” was used for structures with metal ions to account
for ionic/covalent interactions between them and the protein residues. The validity
of the default multipliers was inspected with a visual check of the ion position in
PyMOL to ensure reasonable structure geometry was generated by the relax
algorithm.
Rosetta algorithms
The flexible protein modeling software suite Rosetta (RosettaCommons.org) was
used to analyze the crystal structures of the CRISPR-Cas systems in this study.
To generate the relevant sequences from the experimental datasets, the
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rna.default algorithm was used to mutate the DNA and RNA sequences of the
starting Protein Data Bank (PDB) structures downloaded from RCSB (Table 1).
Three main algorithms were used to compute energy profiles of the PDB
structures. Briefly, the Scoring algorithm generates Rosetta Energy Units (REUs)
for each residue based on the positions of the atoms and 19 sub-score algorithms
assessing attractive, repulsive and hydrogen bond forces 116. The per-residue
energies are summed to generate the score of the entire structure. The
Minimization algorithm chooses a descent vector, calling a variation of the scoring
algorithms after each iteration to determine the next vector until it finds a local
energy minimum. The algorithm ends when the fractional tolerance (deviation from
true minimum value) is met, which was set to 0.0001 in this study. The chosen
Minimization algorithm “lbfgs_armijo_monotone” uses inexact line search to allow
for temporary increases in energy in order to avoid shallow local minima. The final
algorithm, Relax, calls the Minimization algorithm and the Packer alternately. The
Packer uses Monte Carlo sampling to optimize the positions of side chains.
Because of its stochastic nature, the Relax algorithm is used in combination with
ensembles of structures in our protocol to obtain a statistically relevant sampling.
For the generation of the initial structure relaxation the Relax algorithm was
repeated 10 times while for relaxation of on-target structures, the algorithm was
called 5 times.
Ensemble generation
To generate an appropriate ensemble of structures in the Rosetta
computational environment, the protocol of the Rosetta-Vienna ddG method was
largely followed118 and adapted to accommodate the larger structures and thus
longer computational times. In summary, the initial PDB structure downloaded
from RCSB (www.rcsb.org, Table 1) was relaxed to generate a 20-structure
ensemble (Figure 10). The 5 structures with the lowest total energies were used
to create a 5-structure ensemble. For each structure in the ensemble, a set of
relaxed and minimized structures followed by successive truncation of the RNA
molecule were generated (Figure 10).
In order to investigate the effect of larger ensemble size on the correlation
to experimental values, a 20-structure ensemble for each on-target structure
(Figure 10) was created for each of the 5 ensembles of the 5F9R structure,
generating a total ensemble size of 100. The process of off-target structure
minimization and subsequent truncation and scoring was followed for each
ensemble.
Statistical analysis for correlation to experimental data
For spCas9, the MLE (maximum likelihood estimation) DNA cleavage
values from Hsu et al. was used36. On-target investigation used the CRISPRscan
sgRNA library dataset94. Cas12 (Cpf1) experimental values were obtained by
normalizing read counts in Kleinstiver et al. 201635 to their on-target values.
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Results and Discussion
On-target activity is not predicted by heterotriplex energetics
The first investigation into a protein modeling approach for investigating CRISPRCas single-effector activity was to determine potential correlation of the
experimentally determined on-target activity with output from Rosetta’s Pose
calculations. The sgRNA sequences from the CRISPRscan dataset94 were used
as the basis for the training set. These structures were prepared for simulation
using the standard rna_mutate, minimize, and relax Rosetta algorithms. Using the
19 subscores and total score (sum of 19 subscores) from each simulated structure
as parameters, we performed a multivariate regression to identify potential
correlation (Figure 11). No significant correlation between measured experimental
on-target activity and the energetics of the structure could be detected. This result
is in agreement with a variety of studies that point to the dominant role of “absolute”
activity factors such as genomic superstructure, cell-state, and transcription control
machinery that might either inhibit or enable the Cas protein from binding to the
desired target site38,111,112. This lack of correlation was further anticipated by the
nature of the Rosetta algorithm, because the simulation calculates conformation
structure with REUs that may correlate but are not exact thermodynamic values.
Finally, the value output from the Rosetta protocol is a final structure value and
does not give insight into the transition state of R-loop formation that has been
experimentally shown to be the governing factor for CRISPR-Cas activity.
Truncation scoring approximates R-loop formation energetics
To simulate the passage through R-loop formation, we estimated this dynamic by
calculating truncated DNA structures in the static Rosetta environment. Each of
these structures represents a snapshot of the intermediate binding states that the
complex passes through as the R-loop is formed. The differences in the energy
values between the matched (on-target) structure and the mismatched (off-target)
structures is then calculated and used to approximate the ΔΔG at each stage of
the R-loop transition phase. This procedure is used to account for the intrinsic
energy change to the system in the Rosetta environment when more molecules
are added (Figure 12). To identify only relevant forces and not random differences
due to conformational state found with Monte Carlo minimization in distal protein
residues, we used energy scores from only the RNA and DNA molecules.
Figure 12 demonstrates this procedure for both spCas9 and lbCas12
structures showing the resulting ΔΔG proxy values for a structure with a given
mismatch profile. In many cases the proxy values align with exactly with the
location of the mismatch, although destabilization of neighboring nucleotides can
also be seen in the lbCas12 triple mismatch result. A distinct advantage of using
this method is the inherently agnostic nature to the type of mismatches. In
particular, previously developed algorithms30,36,119,120 could not to systematically
account for deletions or insertions, as they are difficult to account for in position
matrix. The proxy scores resulting from the truncation exercise identify favorable
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interactions, thereby probing movements of the entire DNA and RNA chains that
are difficult to account for when relying on index specific mismatch matrices for
scoring. Such generalizability is important for detecting the broadest range of offtarget activity.
Correlation of ΔΔG proxy values to experimental off-target activity
We hypothesized that the ΔΔG proxy values could serve as an insight into the
energy barriers faced by a particular structure as it passes through R-loop binding
transition state. As signaled from other studies, the closer the barrier to the initial
formation of the R-loop (PAM proximal barriers) the less likely binding and
therefore cleavage would occur. This is due to the nature of the DNA unwinding
by the Cas9 (and Cas12) protein complex, which starts its unwinding proximal to
the PAM sequence. To quantify this effect using our Rosetta generated values,
we defined energy barriers as ΔΔG proxy values that are deviated from a defined
Z-score from the average across the entire structure (Z = 0.5 or 1.0). In addition,
the cumulative effect of multiple barriers should serve as a larger detriment to
binding. The larger the positive value of the ΔΔG proxy value provided by Rosetta
is likely to indicate a taller thermodynamic wall. Finally, the more stable final
configuration is, the greater the likelihood of structures makes it to the final
conformation, as suggested by the principles of chemical equilibrium. Using our
off target experimental dataset of 712 off-target structures36, we then investigated
various mathematical formulations of our hypothesized contributors to off-target
activity.
The single largest contributor to correlation with experimental activity is the
cumulative effect of ΔΔG barriers, defined as the sum of values with Z-scores
above the threshold (Z>1.0). Further, dividing this by the location of the barrier
relative to the PAM sequence weights barriers closer to the initiation of the
structure because it is more inhibitory to Cas activity. Further addition of the total
structures ΔG, calculated by summing all ΔΔG proxy values, achieves the
maximum possible correlation (Spearman) and predictive performance. A natural
logarithm on the sum of the ΔΔG proxy values was used to appropriately weigh
the effect of the ΔΔG and ΔG scores into one equation due to the approximate
exponential rise in relative ΔΔG proxy values as one moves farther from the PAM,
i.e., the center of the protein structure opening up to Rosetta larger movements in
residues). Predictive performance was calculated by using a cutoff of 0.01% MLE
(maximum likelihood estimation) for cleavage, which is used to define the
experimental values of the relativistic operating curve (ROC, Figure 13B). The
area-under-curve calculation provides a singular metric by which to assess the
true/false positive ratio of the Rosetta algorithm and derived equation on a
spectrum of threshold values.
Equation 3.1
𝑛

RosCas = ∑
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𝑖

26

+ 𝛥𝐺

𝑍=
𝑛

𝛥𝛥𝐺𝑖 − ̅̅̅̅̅̅
𝛥𝛥𝐺
𝜎𝛥𝛥𝐺

𝛥𝐺 = ∑ 𝛥𝛥𝐺𝑖 , 𝑛 = 𝑔𝑅𝑁𝐴 𝑙𝑒𝑛𝑔𝑡ℎ
𝑖

The final formulation of the equation used to correlate the Rosetta ΔΔG proxy value
output, termed RosCas (Equation 3.1).
The results for Cas9 simulation outcompetes the best performing
convolutional neural networks with a Spearman correlation of 0.5 and a best-inclass AUC (area-under-curve) from a relativistic operating curve of 0.860 (Figure
13). RosCas is unique because it does not rely on any sort of machine learning
(i.e. training) but biophysical and chemical equilibrium first principles. This
formulation can be applied for many different types of Cas systems, so long as a
viable crystal structure has been resolved.
An important aspect of using Rosetta for assessing thermodynamic
properties of structures—in particular snapshots of intermediate states—is the use
of an ensemble average of structures to smooth the stochasticity of Monte Carlo
algorithm results. To measure the impact of the size of the ensemble, we
calculated the Spearman and Pearson correlation values of different ensemble
configurations of the computed values to experimental data. Figure 14 shows that
averaging the ensembles improves the correlation to experimental data. In
particular, averaging the highest performing ensembles may offer slight
improvements in Pearson correlation over a full ensemble average, suggesting
that given the computational power, by running more ensembles and selecting the
top performers before averaging may increase performance of the Rosetta-based
prediction presented in this work.
In addition to its predictive power, the data generated through the
simulations used by RosCas can also provide greater mechanistic insight into
certain off-target pairings. Notably, the effect of a single mismatch is often felt by
the proximal nucleotides, which can either result in a local stabilizing or
destabilizing effect (Figure 12A). When a significant number of mismatches are
located in close proximity, this local effect expands across all nucleotides in
question, essentially cancelling out any stabilizing effect of the matched
nucleotides in the region (Figure 12B). Further investigations into these truncation
diagrams with different datasets and Cas nucleases will undoubtedly provide
further insight into the complicated nature of non-specific CRISPR-Cas activity.
Cas12 dataset highlights genomic loci contribution to off-target activity
Due to the success of the modeling exercise with the spCas9 dataset, we then
performed our RosCas protocol to two Cas12 (lbCas12, asCas12) structures with
guide-RNA sequences from Kleinstiver et al. dataset35. This dataset was unique
because many of the targeted sequences had degenerate sequences with multiple
hits across the genome. It should be noted that only a single RosCas score is
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given to the multiple off-target hits because the RosCas protocol only takes into
account sequence identity.
The result of Cas12 simulation shows that truncation scoring can
approximate R-loop formation energetics (Figure 15B). Destabilization of
neighboring nucleotides can be significantly affected even by a single upstream
mismatch that is close to PAM. We observed there is no correlation between
RosCas scores and experimental values (Figure 15A). The main reason was likely
due to the degeneracy of the Kleinstiver et al.’s dataset coupled with the large
variability of experimental (GUIDEseq 25) values coming from identical sequence
mismatch profiles.
Due to the success of the spCas9 exercise, we sought to employ RosCas
as a relative activity normalizing factor to probe the effects of genome location on
the absolute activity of a given target. RosCas is not only generalizable to other
Cas nuclease structures, but its lack of reliance on dataset-specific training allows
it to be used as a relative activity guideline on any experiment spanning multiple
experimental conditions and cell lines. To this end, the difference between the
RosCas score and the normalized (via on-target) GUIDESeq value for each offtarget hit was mapped to determine the targetability of each locus (Figure 15C).
This exercise resulting in the successful mapping of the accessibility of genomic
sites to Cas12 across the human HEK293T cell line. This novel capability of
RosCas, enabled by its incorporation of all relative activity factors, shows the
promise of using such assays to gain a greater understanding of genome
accessibility. A couple obvious limitations exist that could be mitigated through
experimental design. First, the lack of sgRNA tiling within a locus leaves the exact
nature of the absolute activity a mystery. By investigating variation across
kilobase-scale regions, the resolution of genomic accessibility could be further
enhanced. Second, the use of larger variety of guide sequences could prevent
confounding effects from on-target normalization. Ultimately, the use of RosCas
for predicting relative activity with accompanied mechanistic insight is a valuable
complement to experimental off-target activity screens for both validating off-target
activity and further investigating CRISPR-Cas interactions with cell lines and
genomes of interest.

Conclusions
This work has generated a computational model and subsequent workflow for
evaluating off-target activity of any single-effector Cas enzyme. The use of
truncated DNA structures to identify energy barriers during R-loop formation is the
single greatest contributor to the fidelity of the model. Further, the strength of
correlation allows the model presented to be used to interrogate the role of other
factors influencing total (absolute) off-target activity by controlling for the relative
activity in a precise and accurate manner. Showing this model is reliable with only
a small ensemble increases the value of the approach as this reduces
computational time, making it an attractive alternative to large-scale experimental
screening approaches. This method can be coupled with sequence alignment
28

algorithms (e.g. BLAST, CASPER) to identify putative off-target sites, adding
higher resolution to activity prediction. Finally, this method can act as a
complement to unbiased genome-wide off target search to evaluate genomic sites
that are more prone to CRISPR-Cas activity as shown in the Cas12 data. Taken
collectively, this work results in the expansion of off-target analysis to a suite of
unexplored Cas enzymes, both engineered and natural.
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CHAPTER FOUR
IN SILICO PROCESSING OF THE COMPLETE CRISPR-CAS
SPACER SPACE FOR IDENTIFICATION OF PAM SEQUENCES
Summary: A version of this chapter was originally published by Brian Mendoza and
Cong T. Trinh: “In Silico Processing of the Complete CRISPR-Cas Spacer Space
for Identification of PAM Sequences”121

Introduction
The prokaryotic adaptive immune systems, CRISPR (Clustered Regularly
Interspaced Short Palindromic Repeats), are near-ubiquitous across the archaea
and bacterial kingdoms and exhibit extensive diversity 17.
Despite this
heterogeneity, there exists three fundamental biochemical behaviors shared
among all CRISPR-Cas systems: acquisition, expression, and interference 18. The
first stage, acquisition, is relatively conserved across species and involves the
process by which foreign DNA (or RNA) is acquired and inserted into the CRISPR
array. The second step involves the expression of the acquired sequences of the
array and processing them into short RNAs (crRNA). Third, the interference stage
uses either a single (Class 2) or multi-unit (Class 1) effector complex to bind the
processed crRNAs for recognition and cleavage of the foreign DNA/RNA. To avoid
self-cleavage of the sequence within the CRISPR array, a short sequence known
as a protospacer adjacent motif or PAM, appears just outside the recognition
sequence. The PAM serves as a checkpoint to ensure the correct target has been
found 3,70,122. This step is critical to the interference step, as even a perfectly
matched guide RNA sequence without the proper PAM sequence will fail to
achieve any activity 3,36.
Significant research has been devoted to the classification of CRISPR-Cas
systems to help define common functionalities 16,17. The current system contains
two main classes, distinguished by a single (Class 2) or multi (Class 1) protein
effector complex and further classified into 6 types and 22 subtypes 17,123.
Experimental studies have shown however that PAM sequences are particularly
diverse and may vary from species to species even within subtypes 124. The
knowledge of the PAM sequence is thus critical for harnessing CRISPR-Cas
systems, and the current classification system offers incomplete insight into a
species’ PAM sequence. As research increasingly branches out from the canonical
Cas9 of Streptococcus pyogenes and its Type II relatives to discover novel
functionalities in alternate CRISPR-Cas systems, the ability to study these systems
will be limited to the speed in which PAM sequences can be determined 5,32.
Three common methods exist for determining the PAM sequence and have
been used to varying degrees of efficacy: in vivo selection 19,21,25,125, in vitro assays
25,59,126, and in silico analysis 3,127,128. The first two methods are experimentally
driven and provide the most accurate determination of the PAM sequence.
However, they require time-intensive experimental procedures, and rely on
effective molecular biology tools suited to the organism in question to be previously
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developed (in vivo), or the ability to clone out and express an active system
heterologously (in vitro) 70. In contrast, the in silico method uses sequence
similarity of existing spacers in an organism’s genome to that of invasive genetic
elements to suggest a potential PAM sequence 127. While the method is less
accurate and complete than that of its experimental counterparts, it requires simply
a query of CRISPR array(s) against potential target genomes, which are readily
available in ever-expanding sequencing databases. Although this method has
been performed for a number of organisms to elucidate potential PAM sequences,
a comprehensive PAM analysis of all available CRISPR-carrying organisms has
not previously been performed.
We have recently presented the CRISPR Associated Software for Pathway
Engineering and Research (CASPER) for enhanced on- and off-target prediction
of gRNA designs and multi-targeting analysis for single and consortium of
organisms using various Cas enzymes 43. In this study, we have developed the
CASPERpam algorithm to systematically and comprehensively perform a
complete PAM analysis for all prokaryotes in the NCBI database for which
sufficient data exists to investigate potential protospacer matches. From the
generated PAM sequence database, we were able to infer certain design principles
that are relevant for understanding PAM diversity and provide a baseline for further
experimental studies including PAM assays. The PAM sequence database and
categories have been integrated into the CASPER platform as a new feature. We
anticipate the CASPERpam tool will enable further research and engineering of
prokaryotes using their native CRISPR machinery and aid in the development of
novel CRISPR-Cas systems for heterologous expression in eukaryotes.

Methods
This section presents the CASPERpam algorithm for processing the complete
CRISPR-Cas spacer space to identify PAM sequences to complement the
resources of CASPER 43 for research in novel CRISPR-Cas systems. The
CASPERpam algorithm contains 5 steps for spacer collection, genome collection,
and PAM detection and analysis (Figure 16).
Spacer collection for PAM analysis
Based on the 720,391 spacers detected across 42,352 CRISPR arrays from
30,389 assemblies collected and analyzed by Shmakov et al. 129, a total of 26,364
hits were detected by a BLASTN search across the viral (13,885 assemblies),
plasmid (11,218 assemblies), and bacterial/prokaryotic (129,209 assemblies)
genome databases of NCBI, using the 95% sequence identity and 95% coverage
constraints to gather only hits with sufficient similarity (Step 1, Figure 17). Self-hits
were removed by discarding protospacers with identical assembly and location
coordinates as the spacer. There were no spacers that generated multiple hits. To
identify a PAM sequence, we collected the protospacer sequence and included an
additional 10 nucleotides on either side (the “collected” sequence). Because the
protospacer sequence itself may only be a partial match to the spacer, we
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extrapolated endpoints of the spacer within the collected sequence. Specifically,
the spacer and collected sequences were aligned by finding the largest perfectly
matched sequence shared between the two sequences. Then the indices of the
spacer sequence’s start and end within the collected sequence were used to define
the locations of the flanking sequences.
Genome collection for PAM analysis
From the spacer collection suitable for PAM analysis, we could narrow the number
of assemblies from 30,389 to 6,955 (Step 2, Figure 17). Since multiple assemblies
can belong to the same species, we clustered them at the species level to create
a total of 1,493 species (Step 3, Figure 17). By choosing species with at least 2
spacer hits, we further reduced the number of species from 1,493 to 1,049 for
which we could search for PAMs (Step 4, Figure 17). In our analysis, strains and
substrains were grouped together under a common species. While in some rare
cases it is possible that PAM sequences might differ between strains and
substrains due to random mutation or perhaps horizontal gene transfer of CRISPRCas machinery among strains 16, we would not have been able to perform further
analysis in a vast majority of species due to the limited number of protospacers
belonging to each substrain.
PAM detection and analysis
The Cas type was used to determine whether a PAM was located 5’ (upstream) or
3’ (downstream) of the protospacer (Step 5, Figure 17). For type I, III (rPAM), IV,
and V systems, the PAM has been either shown or inferred to occur 5’ on the same
strand of the protospacer sequence 12,130,131. Type II systems, however, have
PAMs 3’ along the same strand of the protospacer sequence. Each species was
assigned a CRISPR-Cas system based on the data provided by Makarova et al.
16,17. For those species that did not appear in the prior classification studies, the
genus was used to match the species to a relative and its Cas type was inferred
from the type of its relative.
To obtain the PAM for each of the 1,049 species, bitwise scoring 132 was
used to determine the important positions (Step 5, Figure 17). Positions with an
R-score higher than a half a standard deviation above the mean were considered
significant. As an additional constraint, the R-scores for positions farther than 5
nucleotides away from the spacer sequence were subject to the more stringent
requirement of full standard deviation above the mean to further filter out noise
from positions unlikely to contribute to the PAM sequence. For Type II-C systems
where nucleotide positions 5-8 often contain the PAM sequence, the R-scores
were high enough such that the full standard deviation requirement did not alter
the predicted PAM sequence. Within each significant position, if a nucleotide had
a relative frequency higher than 0.5, it was considered to be the consensus
nucleotide. If no nucleotide was higher than 0.5, the nucleotide(s) that had relative
frequency greater than 0.25 were considered to be part of the PAM.
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The R tool ggseqlogo was used to create a bitwise graph for each species
to determine the PAM from the appropriate flanking sequence (5’ or 3’) 132. In
many cases, sequences obtained were shorter than 10 nucleotides due to the
spacer index starting in the flanking sequence and/or appearing at the end of an
assembly or near an ambiguous sequence (set of ‘N’s). To satisfy the symmetrical
sequence length requirement of ggseqlogo, flanking sequences smaller than 6
were discarded and the remaining were truncated to the length of the smallest
sequence.
Computation
NCBI servers were used solely for query purposes (https://www.ncbi.nlm.nih.gov).
All genomes needed to identify flanking sequences of the protospacers were
downloaded from NCBI (RefSeq/GenBank) onto an external hard drive (as of
11/24/2017). Python (ver. 3.6) was used to process the data and sequences. R
(ver. 3.4.3) statistical programming language was used to run ggseqlogo and
generate the sequence bitwise plots 132. All computational work was performed on
a Macintosh MacBook Pro computer (Apple Inc., 2013). Code is available at
https://github.com/TrinhLab/CASPERpam.

Results and Discussion
CASPERpam is a valuable tool when attempting to harness the power of CRISPRCas in a poorly studied organism. It can be used as a starting point for determining
the PAM sequence necessary for interference with the native Cas machinery,
which may be more efficient than heterologously expressed Cas proteins and
arrays 128. It also provides another level of classification that can be used as a
benchmark for comparing and understanding functionality with other systems with
similarly predicted or experimental PAMs. Our results highlight the algorithms
utility in these areas and offers unique insights as a result of its large-scale
analysis.
Predictive PAM sequences match experimental evidence
To validate the CASPERpam algorithm, we compared the predicted and
experimentally derived PAM sequences for a set of 12 species spanning both
CRISPR classes and multiple types/subtypes (Figure 18). Our result shows that
CASPERpam could generate the exact match (green boxes) for the experimentally
derived PAM sequences in 3 of the 12 species including P. aeruginosa (Figure
2A), Acinetobacter baumannii (Figure 18B), and E. coli (Figure 18C). In addition,
we found strong correlation (blue boxes) between the experimental and predicted
PAM sequences of 4 species: S. pyogenes (Figure 18D), C. difficile (Figure 18E),
L. bacterium (Figure 18F), and B. halodurans (Figure 18G). An additional two
species had weak correlation (yellow boxes): S. thermophilus (Figure 18H) and T.
denticola (Figure 18I). Weak correlation species are defined here as partial
matches where half or less of the predicted PAM matched with the experimentally
derived sequence. Finally, we did not find a match (red boxes) for the 3 remaining
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species: N. meningitidis (Figure 18J), C. jejuni (Figure 18K), and S. aureus (Figure
18L).
In our analysis, we observed that the number of complete and strong partial
matches appeared in species that have relatively high protospacers (hits) and
consensus Cas-types (Table 2). In contrast, the non-matches correlated to a
smaller number of protospacers. A notable exception is Bacillus halodurans, which
despite a relatively low number of protospacers returned a strong match to its
experimental PAM. Interestingly, type II species seem particularly prone to
inaccurate predictions of the PAM sequence, despite large amounts of
protospacers and a consensus Cas-type in certain scenarios.
Because
sequencing results belong to existing phages and other mobile genetic elements,
i.e. those that have survived and escaped CRISPR-Cas interference, protospacercarrying phages may have acquired favorable mutations in the PAM identification
region, contributing to an incorrect PAM sequence being derived by CASPERpam.
This scenario may be exaggerated in with type II systems due to the significant
differences in the mechanisms of both acquisition and interference between type
II (Class 2) and other Class I systems [6, 12-14]122,133,134. Further studies on
common means of escape (e.g. anti-CRISPRs) could further elucidate this
phenomenon 135,136.
Overall, the CASPERpam algorithm provides putative PAM sequences with
confidence of prediction (PamCoS) scores for 1,049 species, revealing consensus
motifs particularly among Class 1 systems. The result also highlights the
importance of a more quantitative metric to determine whether the information
available for a given species is sufficient to predict its putative PAMs, as presented
in the next section.
Quantification of the quality of in silico PAM prediction
To quantify the accuracy of PAM prediction for a given species, we developed a
metric, the PAM confidence score (PamCoS), to determine whether the
information obtained from the database (NCBI RefSeq) is of sufficient quantity and
quality. PamCoS is calculated as follows:
Equation 4.1

𝐶𝑚 1
× − 𝐻𝑎𝑣𝑔𝑑𝑒𝑣 )
𝐶𝑇 𝑁𝑆
In Equation 4.1, the value h represents the number of protospacers (hits) from all
the spacers. Cm and CT refer to the number of detected Cas arrays that match the
consensus type for a designated species and the total number of arrays,
respectively17. The consensus type is defined as the Cas subtype that appears the
most. For example, an organism with three arrays, two of which are of Type I-B
and one Type II-A would have a consensus type of Type I-B with Cm/CT = 0.67. Ns
= 1 for a species with a well-defined consensus Cas type. However, if a species is
not found in the PAMCoS classification database121, the value of NS is increased
by 1 for every level up in the phylogenetic tree that the species must be traced until
𝑃𝑎𝑚𝐶𝑜𝑆 = ℎ × (
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matching a relative. The value Havgdev is the average deviation of the Shannon
entropy term for each of the positions deemed as significant contributors to the
PAM sequence (denoted by the subscript “sig”). Havgdev is calculated as follows:
Equation 4.2

𝐻𝑎𝑣𝑔𝑑𝑒𝑣 =

∑ 𝐻𝑖,𝑠𝑖𝑔 − 𝐻𝑎𝑣𝑔
𝑛𝑠𝑖𝑔

Equation 4.3

𝐻𝑖 = − ∑ 𝑓𝑎,𝑖 × 𝑙𝑜𝑔2 𝑓𝑎,𝑖
In Equation 4.2, Hi,sig is the Shannon entropy of a significant position; H avg
represents the average Shannon entropy across all positions in the flanking
sequence; and nsig is the number of significant positions. The fa,i term in Equation
4.3 is the relative frequency of a given nucleotide “a” at position i.
We used PamCoS to score all 1049 species in the CASPERpam produced
database (Figure 17 and Table 2). The species with the top 40 PamCoS scores
are presented in Table 2, along with a select number of additional species for which
an experimentally derived PAM sequence is available. The relative PamCoS score
is shown in this table, where the scores have been normalized (0 to 100) based on
the highest PamCoS score of Pseudomonas aeruginosa (2851.61) in the
database. High PamCoS scores correlate well with accurate predictions by
CASPERpam of the species with experimentally derived PAMs, with the exception
of type II species. It does seem however that after a certain PamCoS threshold,
the prediction for type II species becomes effective. For instance, S. agalactiae
and S. suis, two species with type II-A CRISPR-Cas systems, have PamCoS
scores over 400 (Table 2) and exhibit the NGG motif as their predicted PAM, the
same as their experimentally proven close relative S. pyogenes. This suggests
that a PamCoS score of 400 can be used as a minimum threshold to guarantee
accurate PAM prediction for all Cas types. While only 8 species in the NCBI
RefSeq database currently satisfy this criteria, further sequencing efforts of
microbial genomes will aid in providing the necessary information for accurate in
silico PAM prediction.
To assign a more flexible cutoff for the currently available data and using
the PamCoS scores of species with known PAMs, a score above 10 (0.35 relative
PamCoS to P. aeruginosa) seemed a reasonable threshold for PAM prediction.
This however is not a strict cutoff as the prediction of the PAM for B. halodurans
proves lower PamCoS scoring species may still lead to reasonably accurate
PAMs. Lower PamCoS rated species must be viewed with some skepticism,
however. Due to the smaller number of protospacers, even when accompanied by
relatively low Shannon entropy values, these predicted sequences are more
sensitive to false assignment of significant positions and nucleotides. Further,
false sequence noise may be compounded by potential Cas type ambiguity, as a
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non-consensus Cas-type hit may be incorporated into the PAM sequence
prediction.
Overall, use of the PamCoS score enhances in silico PAM analysis.
Notably, PamCoS allows the PAM sequences produced by CASPERpam to be
assessed for their relative accuracy and aid in narrowing the search space of
sequences for experimental validation. For instance, species with low PamCoS
scores should be validated with a comprehensive in vitro or in vivo methodology,
using the results of CASPERpam as supplemental validation of experimental
discovery. On the other hand, species with relatively high PamCoS scores may
allow the CASPERpam prediction to be supplemented with only minimal
experimentation to provide confirmation of the predicted sequence.
Based on CASPERpam analysis, the number of species with PamCoS
scores over the threshold value of 10 (221) represents a very small portion of the
tens of thousands of bacterial and archaeal species that have been sequenced. It
does however represent an order of magnitude increase in the number of CRISPRCas systems that have had a PAM sequence predicted or validated. The result
provides a starting point to harness the extensive diversity present across the
CRISPR-Cas space.
Of the 221 species above the threshold value, 78% had a Class 1 system,
an understudied relative to their more popular single effector Class 2 cousins.
Even though the Type I system appears to have a greater variety in their PAM
sequences 137, only a select number of nucleotide patterns of PAMs are commonly
used. These select PAM motifs are not confined to a single Cas type, rather they
are spread across systems (Figure 19A). One potential explanation is that the PAM
motif of Class 1 multi-effector systems is likely subject to some degree of horizontal
gene transfer. Particularly, the Cas8/10 and Cas1/2 proteins, likely responsible for
PAM recognition during the interference and acquisition steps respectively, may
be traded within microbial communities, creating within a species hybrid Class 1
systems with a clearly assigned Cas-type using a PAM largely associated with
another 15,17,138.
PAM prediction highlights diversity and patterns within and between Cas
types
To analyze the PAM diversity across different Cas-types, we gathered all PAM
motifs of the 221 species above the threshold value and grouped them into families
of closely associated motifs. We identified common patterns and assigned 5’ and
3’ PAM sequence categories and/or subcategories to these sets for 218 species
(Figures 19B and 19C). Each category/subcategory is defined by a consensus
motif that captures the general pattern. Three species from the original set of 221
species, including Proteus mirabilis, Bifidobacterium longum, and the Eubacterium
sp., were removed from the analysis because CASPERpam could not assign either
a consensus Cas-type or the PAM motif was clearly the result of multiple Castypes.
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The 5’ PAM sequences contain 8 categories (J, K, L, M, N, O, P, and Q)
(Figure 19A, 19B). The K and Q categories represent 61% of PAMs located on the
5’ end. The ‘CC’ PAM of the Q category and ‘TTC’ PAM of K are heavily
represented (Figure 19A, 19B). These groups are disproportionately associated
with types I-F and I-B respectively; however, they are not exclusive and also
appear in species with other Cas-types. The PAM sequence space of the 170
species with reliable 5’ PAMs (as defined by the confidence score) can be seen
mapped together in Figure 19A.
It is striking to observe that none of the Cas types nor subtypes map to a
unique PAM category, with the exception of a few types with less than 5 species
represented in the sample (e.g. Cas-III-B and Cas-I-A). This result supports the
view that the current CRISPR-Cas classification method is imperfect likely due to
the CRISPR-Cas systems’ similarity and modularity prone to horizontal gene
transfer 17. It also prevents a simple classification based on sequence homology
or phylogenetics from perfectly partitioning the heterogeneity of these systems.
The 3’ PAM sequences consists of 3 categories (X, Y, and Z) with the X
category broken into a further 4 subcategories (X1, X2, X3, X4) (Figure 19C).
Among the 3’ PAM sequences, the category Y, with the NGG consensus motif, is
quite common, representing 25% of identified PAMs (Figures 19C, 19D). The
category X, although representing two-thirds of identified PAMs, has a much more
broadly defined consensus motif (N)nW and lent itself to subcategorization of which
none reached a representation comparable to the Y category (Figures 19C, 19D).
The ‘NGG’ PAM found in the Y category is the most represented PAM motif, but
CASPERpam only identified two such species, with an exact ‘NGG’ PAM. Other
PAMs in the category were defined more broadly, with adenines and sometimes
thymines also highly represented at the 2 and 3 positions creating an NRR, and
NKK PAMs. This result is consistent with experimental evidence that type II-A
systems such as the canonical S. pyogenes exhibited some affinity for a ‘NAG’
PAM. Even though this detected promiscuity may be overstated by the in silico
analysis, it highlights the importance of future experimental studies on species with
a PAM falling in the Y category to focus on the relative affinity for guanine over
adenine or thymine.
The PAM categorization exercise of the highest PamCoS scoring
organisms is useful in highlighting both heterogeneity of PAMs as well as some
clear categorical delineations, particularly for Class 1 systems (namely K, L, M and
Q). These categories can be used to reinforce or place further doubt upon the
CASPERpam predicted PAM motif of organisms with substantially lower PamCoS
scores. For example, despite a low relative PamCoS score of 0.105, the putative
PAM for A. suryakundensis is TTN, which agrees well with other Cas I-B systems
as a group K motif, lending further confidence to the prediction.
Based on the 5’ PAM space and the X and Z 3’ PAM categories, we clearly
observed that there exists a high level of non-specificity in many PAM interacting
domains. It cannot be discounted that this diversity may be underrepresented by
the in silico technique, as only those with particularly effective targeting will appear
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across the targeted genomes 70. On the other hand, PAM sequences are likely to
be mutated for phages to survive, and thus sequencing assemblies may not
represent the true form of the PAM sequence, but rather an overrepresentation of
a random set of mutated sequences despite a close spacer match. Such a
hypothesis would result in the in silico process revealing greater non-specificity
than would be shown experimentally. Likely, these two effects are both present,
and result in some overly specific as well as some overly promiscuous sequence
predictions from the in silico method.
Conclusion
To harness a large, diverse class of alternative CRISPR-Cas systems outside of
the group of well studied Cas9 and Cas12 variants, it is critical to identify PAM
sequences for characterizing these novel CRISPR-Cas systems. Development of
CASPERpam provides a powerful tool to predict PAMs for a given species and
allows subsequent experiments to change from a determination to a validation
study. While some previous studies have performed such an in silico PAM analysis
for a select number of species to guide experimental studies of native CRISPRCas systems, this study has performed an exhaustive PAM analysis for every
CRISPR-Cas carrying bacterial and archaeal genome in the NCBI database. As
research moves into investigating a greater number of CRISPR-Cas systems with
novel functionalities, CASPERpam will be a useful bioinformatic tool for those
seeking to understand and harness the diversity of CRISPR-Cas systems.
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CHAPTER FIVE
DEVELOPMENT OF CRISPR-CAS ANTIFUNGALS
Summary: A version of this chapter is to be submitted to PNAS under the title:
“Potency of CRISPR-Cas antifungals is enhanced by co-targeting DNA repair and
growth regulatory machinery at the genetic level” by Brian Mendoza, Xianliang
Zheng, Jared Clements, and Cong T. Trinh.

Introduction
Fungi represent a particularly resistant class of pathogens that are the source of
dysbiosis in a variety of societally relevant hosts and environments 139,140. Damage
to agricultural and sensitive ecosystems due to climate change have exacerbated
the propensity and subsequent damage of outbreaks of Magnaporthe oryzae (rice
and wheat pathogen) and Ascophaera and Aspergillus genus of bee broods141.
Recent examples of fungal outbreaks including the Candida auris “superbug” scare
in 2019 and has prompted increasing research into these relatively rare, but deadly
pathogens142. Even common fungal pathogens such as Candida albicans can
cause significant damage to the host and make them susceptible to dangerous
secondary bacterial infections (e.g. methicillin resistant S. aureus, MRSA)143.
These co-infection scenarios are especially problematic as the fungi provide a safe
haven for the bacteria to propagate, protecting them from treatment with traditional
antibiotics.
At the center of fungal persistence is the robust and complex regulators of
growth that allow them to adapt to a multitude of environments. In particular,
hyphal growth stages, where multinucleated cells elongate and form thick
extracellular matrices, reduce the efficiency of chemical antifungal treatments143145. Current research has identified many key genes that regulate such growth
with the hopes of employing novel treatments to re-sensitize fungi to traditional
antifungals146. While this approach can identify relevant targets, the ability of
deploying such systems in vivo and with successive chemical antifungal treatment
is complicated, not least due to the fact that many of the current antifungal
therapies have moderate levels of toxicity to their animal/plant hosts. Furthermore,
fungal infections often occur in tandem with a bacterial outgrowth, resulting in a
multi-kingdom pathogenesis.
The fungal infections provide a favorable
environment in which the bacteria can grow, protecting them from standard
antibiotics. This symbiotic resistance mechanism is particularly recalcitrant,
requiring treatment of the fungal infection before the bacterial co-infection can even
be addressed.
CRISPR-Cas, the method usually employed for knocking out key genes in
the growth regulation cycle, can also be employed as an antifungal in and of itself,
and has shown such promise in bacterial systems62,63,76,139. Unfortunately, these
studies usually rely on the high lethality of DNA double-strand-breaks (DSBs)
induced by the Cas enzyme. Such a method is ineffective in fungi, as the robust
eukaryotic DNA repair mechanisms can easily counteract DSB activity rendering
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Cas enzymes only mildly (if at all) toxic 48. Therefore, targeting essential genes
with such machinery and ensuring their complete or near-complete knockout is
vital to the efficacy of a CRISPR-Cas based antifungal. The cataloged diversity of
preferred repair mechanisms and their dependence on growth stage in the various
fungal pathogens makes understanding such interactions when faced with
CRISPR-Cas antifungals a large combinatorial problem, prompting the use of a
model organism to first understand the significance of this relationship.
The yeast Saccharomyces cerevisiae is a widely studied model organism
for understanding yeast genetics and biology. Due to its highly curated genome,
the essentiality of its genes is well documented, providing a baseline for
understanding the effectiveness of a transiently expressed CRISPR-Cas system
when targeting such loci. In addition, much is known of its DNA repair pathways
and growth cycles, which exhibit many similarities to the clinically relevant
pathogenic yeasts of the Candida genus147,148. Through screening multiple target
sites across essential genes, this study investigates promising CRISPR-Cas
sequences for use as antifungals. In addition, multiplexing with DNA repair (i.e.
“defensive”) genes, hopes to improve upon the overall lethality of CRISPR-Cas by
removing the ability of the organism to effectively repair the site of the DSB,
resulting in increased lethality of essential gene targeting.

Materials and Methods
Strains and Plasmids
The vectors used were adapted from DiCarlo et al.’s study10. In all studies
(excluding the library verification) a two plasmid system was used, which comprise
of 1) a uracil selectable marker on the plasmid carrying the sgRNA under the
SNR52 promoter on a p426 backbone and 2) Cas9 under the galactose inducible
promoter, GAL1-10 with a leucine selectable marker on a p415 backbone. The
derived vectors containing the sgRNA sequences were built via Phusion PCR in a
40 µL reaction using the p426 plasmid from DiCarlo et al. as a template, sgRNA
Gibson primers with homology for the template and the insert, and a generic primer
with homology for the plasmid. Inserts were constructed using the same template
and complementary primers to the backbone (i.e., one unique to an sgRNA and
one generic). Linker sequences were used to construct an insert with one sgRNA
sequence followed by the SUP4t terminator, a short spacing sequence, and then
another SNR52 promoter with the second sgRNA sequence on the end. These
inserts were inserted into the p426 backbone using the same Gibson assembly
protocol described. Transformations were performed with Top10 E. coli using 5
µL of reacted Gibson Assembly. Upon addition, cells were left on ice for 3 hours
followed by a 45-seconds heat shock at 42˚C. After heat shock, cells were
inoculated in 1 mL of LB and shaken for an hour at 37oC. Cultures were spun down
and concentrated for plating on 100 mg/L Amp plates, where they grew overnight
at 37˚C. Plasmids were run on a gel electrophoresis and confirmed by Sanger
sequencing. About 1 g of each confirmed plasmid with the Cas9 carrying plasmid
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were transformed into S. cerevisiae BY4741 using electroporation (2.1kV, 200
ohm, 25 uF).
Construction of the tetracycline inducible single plasmid utilized the p426
backbone with the SNR52 promoter on the sgRNA operon, but the GAL1-10
promoter controlling Cas9 expression was swapped for the stronger TEF promoter
with a TetO sequence just upstream of the start codon. The sgRNA cloning
procedure was also simplified by removing the operon and adding KpnI and AvrII
sites in its place. Operons expressing sgRNAs were then constructed by overlap
extension PCR using the primers containing the sgRNA sequences followed by
digestion with KpnI and XbaI and then ligation into the KpnI/AvrII cloning sites. This
cloning strategy could be reconstituted by use of an upstream overlap extension
primer that recreated the site on the inserted operon, and hence allowed for
subsequent addition of sgRNA operons via simple digestion and re-ligation of the
plasmid libraries.
Media and culturing conditions
The parent strain used in this study was S288C BY4741. Strains carrying the Cas9
and sgRNA plasmids were grown up in selective media with the appropriate double
auxotrophy (SC-Leu-Ura-) and the desired carbon source (20 g/L glucose for
control, 20 g/L galactose for induction of Cas9). For agar plate serial dilution
assay, strains were grown up in SC-Leu-Ura+ glucose media overnight until
exponential phase was reached. They were then washed 1x with PBS and diluted
10x, 100x, and 500x in PBS before spotting 1 L of sample on the agar plate. For
growth assays in broth, culture prep followed the same incubation followed by PBS
wash. Cultures were then diluted with culture media (SC-Ura-Leu+ carbon source)
to the appropriate starting OD (0.05 or 0.2). Strains were cultured in a Duetz plate
with a working volume of 500 L. OD measurements were taken with a plate reader
(Bio-Tek).
Flow cytometry
To perform viability assessment with flow cytometry, samples were taken and
diluted to within a range of OD 0.1-1.0 to ensure accurate counting by the flow
cytometer. Samples were then further diluted 20x to a total volume of 200 L by
the Guava ViaCount staining solution (EMD Millipore #4000-0041), mixed by
pipetting, and allowed to sit in the dark for 5 minutes. Samples were taken in a 96well round bottom plate and placed in the Guava EasyCyte 6HT flow cytometer.
Gating voltages were calibrated on a 1:1 mixture of exponential phase S288C
strain and a 20-second microwaved sample of the same strain.
Library generation and sequencing
A library of 184 targets was generated using the CASPER (Casper2.org) library
generation feature. Oligos were ordered and annealed with their reverse
complement, then ligated into pBM1000 via golden gate assembly with BsmBI.
The ligation mixture was transformed using NEB DH10B High Efficiency E. coli
41

(C3019I) using the heat-shock protocol described by NEB with the following
modifications: after recovery cells were added directly to selective outgrowth media
(LB + 100 g/mL ampicillin). 5 mL cells were cultured for 18 hours followed by
plasmid extraction with Omega Biotek E.Z.N.A plasmid mini kit (SKU:D6942-01).
Transformation into S. cerevisiae was performed by electroporation described
above with the following modification. After the 1-hour recovery in YPD, cells were
washed twice with PBS and added to a 250 ml baffled Erlenmeyer flask with 25
mL selective media (SC-Uracil) with and without 5 g/mL tetracycline in triplicate.
Samples were taken at 24, 48, and 72 hours post inoculation. Colony PCRs were
performed on the extracted samples, gel confirmed, cleaned and prepped for run
on an Oxford Nanopore MinION R9.4.1 flow cell using the LSK109 ligation
sequencing kit with the native barcoding kit (EXP-NBD104). Results were
analyzed
with
a
custom
python
script
available
on
GitHub
(github.com/TrinhLab/OxfordAlgorithms/) to obtain library sequence distribution.

Results and Discussion
Screening target combinations in S. cerevisiae
The robust DNA repair mechanisms of eukaryotes present a significant hindrance
to the development of CRISPR-Cas based antimicrobials. To investigate the
capability of multiplexing sgRNAs targeting both essential and defensive
machinery, we selected a set of three DNA repair genes (RAD51, RAD52, LIF1)
that are key elements to either homologous recombination (HR) or nonhomologous end-joining (NHEJ) pathways. We then combined these genes with
a select subset of essential genes (n=25) that span multiple functional domains
including central metabolism, replication, and transcription regulation. A serial
dilution assay of strains carrying sgRNAs targeting either essential, defensive, 2x
essential, 2x defensive, or an essential and defensive sgRNA revealed that double
targeting with an essential and defensive gene proved most effective at inhibiting
growth. Figure 20 details the rationale for co-targeting essential and defensive
machinery for CRISPR-Cas antifungal design. In the case of sgRNAs targeting a
single essential locus, the robust DNA repair machinery of eukaryotes can repair
any breaks in at the essential locus, resulting in only a mild toxicity. Targeting a
single defensive gene can result in a knockout but one that still results in a viable
phenotype. Dual or multiplex targeting essential genes can further increase
toxicity but fall short of the efficacy found by targeting essential and defensive
machinery simultaneously, which leaves the cell unable to reliably repair a break
at the essential gene site.
Characterization of high-performing CRISPR-Cas targets
Despite positive results with spotting, further characterization of 18 of the most
promising strains was performed in liquid culture to identify if the lack of growth on
agar could be recreated in the more forgiving liquid monoculture conditions. The
added dimension of growth allowed escaped cells to propagate through the entire
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culture, exemplified by the OD (600 nm) growth curves in Figure 21B. Some
strains however exhibited flat growth curves, suggesting greater efficacy of
CRISPR-Cas growth inhibition. These findings led to the investigation of the state
of viability of these cultures.
To probe the viability of the cultures, a reseeding of the high-performing
Vip60 (RPS21, RAD51) culture was performed to see if the viability could be
recovered. Indeed, after 48 hours, placement of the induced strain in non-inducing
media (glucose as carbon source), was able to recover growth, suggesting that the
CRISPR-Cas is rendering cells dormant. This inference is further supported by
flow cytometry viability assays. Figure 21C highlights the viability results from 6
different strains under 4 different conditions. Strains in the control environmental
scenario (glucose) grow quickly in culture, and by the 48-hour mark when the
sample was taken have exited exponential phase, resulting in a high count of
viable cells but low percentage viability (~25%). Most strains in the galactose
induction media exhibit a profile similar to that of the no-carbon growth condition.
In this case, viability of the cells remains high, but growth is arrested, leaving the
culture in a dormant state comprised of persistent cells. In fact, the galactose
induction of Cas9 does seem to slightly impact the overall viability, particularly in
Vip60 and Vip57. This implies that the CRISPR-Cas antifungal design broadly
creates a dormant phenotype but select combinations of targets can act fungicidal.
Overall, the ability to induce cell death is less pronounced by CRISPR-Cas as it is
using a traditional geneticin (G418) antibiotic treatment, although some
combinations get close on either percent viability (Vip52, Vip76) or viable cell count
(Vip60) metrics. Strains that perform less well exhibit viability profiles similar to that
of growth of that of Vip46, which targets 2 defensive genes (RAD51/RAD51) in
galactose media. In Vip46 there is a slight reduction in both cell viability and total
cell count even when compared with the no carbon scenario, suggesting some
toxicity, although the degree to which this is the case is much less than 5 the cotargeting essential/defensive strains, particularly on the total viable cell count
metric. Viability assay via flow cytometry indicates that identifying target
combinations that cause apoptosis rather than predominantly cellular dormancy
will be critical in future developments of CRISPR-Cas antifungals.
High cell-loading results in more pronounced community escape
In order to understand the robustness of growth suppression in the best performing
strains, we differentially seeded cultures with either an OD of 0.05 (~5.5x105
cells/ml) as in previous experiments, or 0.2 (2.5x10 6 cells/ml). The increase in
cells resulted in a pronounced increase in growth rate in all media types, including
growth in the antibiotic (G418, Geneticin) and the glucose control medium (Figure
22). The resistance to G418 is likely due to the greater number of cells producing
a greater effective concentration of aminoglycoside 3’-phosphotransferases, which
provide the innate resistance via degradation of the antibiotic139.This broad escape
phenomenon induced by higher initial cell concentration—and therefore higher
loading of enzymes responsible for counteracting antimicrobial activity—suggests
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that ongoing kinetics of the culture is also a major driving factor of the escape to
CRISPR-Cas antimicrobials, in contrast to an initial inhibition/inefficiency of the
machinery that eventually allows for escaped cells to proliferate. Further, the more
pronounced rate of growth in the CRISPR-Cas inducing media compared to G418
antibiotic further demonstrates the reduced potency of the CRISPR-Cas system
compared to traditional antibiotics. However, the differential inoculation results
underscore the similarity in escape profiles between traditional small-molecule
antibiotics and CRISPR-Cas, requiring deeper investigation into the roles of
cellular repair machinery and stress response mechanisms to this phenotype.
Targeted amplicon sequencing reveals escape genotypes
As part of our in-depth characterization, we have performed both amplicon and
plasmid re-sequencing using Oxford Nanopore sequencing with the
MinION device. Our results showed that escape populations were comprised of
cells that have somehow avoided mutation to the targeted essential genes as well
as any mutations on the plasmid sequence. A deep sequencing (average
sequencing depth of 20,000x) of 10 essential genes revealed mutation
frequencies of less than 5% for essential genes and 8%, 6%, and 7% for RAD51,
RAD52, and LIF1, respectively (Figure 23). These mutations were dominated by
large deletions (>20bp) resulting in the destruction of the target site but also
resulting in large deletions to the coding sequence of the target gene, implying
gene knockout. However, as these mutated sequences represent a small minority
of
the
total
population,
it
suggests
that
the
homologous
recombination (HR) dominance
over
non-homologous
endjoining (NHEJ) prevents significant edits even at nonessential gene loci. The rapid
division of cells provides a significant amount of template for HR machinery, which
could correspond with the higher inoculated cultures escaping more quickly: a
shortened lag phase enabled high rates of division to overcome the CRISPR-Cas
rate of double strand breaks.
In the co-targeted strains, targeted sequencing revealed that the defensive
gene loci (LIF1/RAD51/RAD52) still experienced a small amount of mutation while
mutations in essential genes were still undetectable, with the exception of a small
deletion (2bp) in the ACC2 gene in the Vip48 strain. The results in the co-targeted
strains are consistent with the single-targeted strains and implies that the surviving
populations, while having an active CRISPR-Cas system, are those that are able
to repair their breaks in essential genes with the accurate HR method. Additionally,
because the defensive genes do not experience a full knockout, a lowered but
sufficient amount of repair proteins are expressed for DNA damage repair of
essential loci. This creates a more toxic effect, but only in select cases does this
eliminate
the
eventual
growth
of
the
population.
Taken
all
together, the competition among kinetics of growth, DNA repair, and CRISPR-Cas
activity are likely the key factors to control antifungal effectiveness. Increasing the
efficiency of knockout through protein/sgRNA selection in conjunction with more
effective ways to reduce DNA repair pathway expression will be important steps
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moving forward should CRISPR-Cas be deployed effectively as an antifungal
therapy.
Library depletion assay for selecting CRISPR-Cas essential gene targets
On-target algorithms are notoriously inaccurate in predicting cleavage efficiency
and only marginally better at identifying binding affinity with dCas9 assays 55. While
DNAse sensitivity assays can clue into certain regions that are more amenable to
editing with decent probability36, granularity within a gene or region of interest is
still unattainable. Therefore, the tiling of the genes of interest is important to select
highly active sgRNA sequences when identifying essential genes for use as
CRISPR-Cas antifungal targets. To determine which sgRNAs targeting essential
genes are the most effective inhibitors of growth, we performed a library screen
with 185 sgRNAs targeting 37 essential genes (Figure 24) using our constructed
single plasmid tetracycline inducible Cas9 system (see Methods).
The
construction and use of a single plasmid with a tetracycline induced Cas9
expression can deconvolute the growth lag from galactose metabolism from the
CRISP-Cas toxicity. The use of a stronger TEF promoter controlled by the Tet
operator (TetO) also increases Cas9 expression while offering tight control via the
introduction of tetracycline. The newly designed system also provides a more
streamlined cloning method, which was necessary for constructing a larger sgRNA
library.
Briefly, log2 fold-changes were generated by comparing cultures with Cas9
induced by 5 g/mL tetracycline against control samples (no tetracycline) at the
same timepoint. The volcano plot (Figure 24A) highlights the 19 sgRNAs with a
high confidence of depletion (p < 0.05). The diversity of gene loci in the subset of
highly depleted guides underscores the importance of sgRNA target selection
necessarily over the selection of essential locus. The result is consistent with
previous studies that suggest the efficiency of the sgRNA is a stronger contributing
factor to antimicrobial efficiency than the target gene itself149. One gene RPL37A
(60S ribosomal subunit protein), however, had 3/5 guide sequences appear in the
highly depleted cutoff region. This could be due either to the sensitivity of S.
cerevisiae to perturbations to this locus or be the result of high accessibility of Cas9
complexes to that locus. Understanding such underlying mechanisms of efficiency
will be important in future studies of promising CRISPR-Cas antifungal targets.
Characterization of promising targets with tetracycline inducible construct
In order to assess both the efficacy of the newly designed system as well as the
efficiency of our library-identified targets, we transformed these constructs
individually into our BY4741 parent strain for further investigation. Initially, we
characterized our single-targeting strains in varying concentrations of tetracycline
while also varying the temperature to identify the optimal conditions for induction
and CRISPR-Cas induced growth suppression. We identified that consistent with
previous studies, tetracycline concentrations above 3 g/mL are sufficient for
strong induction. In addition, growth at 37oC (as opposed to 30oC) only makes a
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marginal increase in the effectiveness of the system, suggesting that the
improvement in Cas9 efficiency at its ideal operation temperature does not result
in significant change to growth profile. Additionally, the results of the library assay
were broadly consistent with the individual strain characterization. For example,
ORC2-3 exhibited the highest log2 fold depletion in the assay and consistently
showed the highest level of growth suppression across all conditions. Three of the
most promising targets: ORC2-3 (origin recognition complex subunit 2), FUN12-3
(translation initiation factor eIF5B), and RPL37A-4 (ribosomal 60S subunit protein),
had co-targeting constructs with RAD51 also build and assessed with highresolution liquid culture measurements using 5 g/ml tetracycline concentration at
30ºC (Figure 25C). Indeed, the co-targeting strains exhibited a substantial
decrease in growth compared to the single-target essential strains over the course
of 60 hours. This result emphasizes the strength of the library and co-targeting
approach for designing the most effective CRISPR-Cas antifungals.

Conclusions
The development of novel antifungal therapies is an area of concern for public
health. This study has highlighted significant design principles and identified
important factors and areas of improvement for harnessing CRISPR-Cas as a
potent and effective antifungal therapy. Importantly, the robust DNA repair
mechanisms encountered in eukaryotic pathogens must be addressed by means
of direct targeting or utilization as a “Trojan Horse” to counteract their role in
directing cells to a persistor phenotype. This study underscores the importance of
such a co-targeting approach to increase CRISPR-Cas antifungal activity. In
addition, informed selection of these defensive genes is needed based on the
pathogen in question, as certain pathways are favored in different species. Finally,
selection of a highly active essential gene-targeting sgRNA plays a significant role
in efficacy, as the kinetic interplay between DNA cleavage and repair governs the
fate of the population. Future work should focus on evaluating the temporal
dimension to determine means of preventing escaped persistor cells from recolonizing a host.
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CHAPTER SIX
IDENTIFICATION OF TARGET AND CAS NUCLEASE
COMBINATIONS FOR ANTIMICROBIALS
Summary: Diversity in prokaryotic DNA repair pathways and the rapid rate of
division generates new problems and opportunities for the design of CRISPR-Cas
antimicrobials. This chapter presents research into combinations of different
techniques within different organisms (Bacillus subtilis, Escherichia coli,
Staphylococcus aureus) and develops certain design rules and delivery strategies
for employing CRISPR-Cas as an antimicrobial. Two key insights are highlighted:
first, the SOS response is a significant barrier to CRISPR-Cas antibacterial
efficacy, but co-targeting relevant regulators is an effective strategy for increasing
potency. Second, the kinetics of rapid cellular division, DNA replication and DNA
repair rates in exponentially dividing bacterial populations outcompete CRISPRCas cleavage kinetics. Using multiple turnover enzymes, preferably with trans
nuclease activity, can help to counter this kinetic imbalance in favor of growth
suppression and cell death.

Introduction
The rise of antimicrobial resistance coupled with the slowing rate of antibiotic
development is a severe concern for public health 62,75,76. This potential crisis has
been partially brought about by the overuse of currently available antibiotics in both
human healthcare and agriculture/animal husbandry. With diminishing financial
incentives to probe antibiotic design space, the problem becomes even worse.
The prokaryotic adaptive immune CRISPR-Cas systems are near-ubiquitous
across the archaea and bacterial kingdoms17. Their inherent selectivity and
adaptability based on the designed guide-RNA sequence can be harnessed for a
new generation of highly selective antimicrobials. The differentiation of CRISPRbased antimicrobials from the traditional chemicals opens up a new design space
while complementing traditional treatments for effective cocktail therapies.
Previous work into the capabilities of the CRISPR-based antimicrobial
system range across a variety of organisms including clinically relevant pathogens,
suggesting this approach is broadly applicable. In general, there exist two
strategies, including CRISPR-Cas induced cell death and the re-sensitization of
the targeted microbe to antibiotics62,63. The first approach (and the focus of this
chapter) requires the CRISPR-Cas machinery to be delivered efficiently and highly
active to prevent the proliferation of untargeted cells. Early studies focused on the
transformation efficiency of CRISPR-Cas systems designed with guide-RNAs
targeting essential elements of the genome or antibiotic resistance markers. While
these studies established the proof-of-concept, the ability to understand escape
mechanisms was limited due to the high level of selective pressure in the
experimental design13. Further studies explored more free systems, and found
that the SOS response in E. coli inhibits the lethality of CRISPR-Cas systems,
which can subsequently be reactivated by using recA knockout mutants 73. Finally,
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the delivery of these systems in a clinical setting needed to be explored, with both
conjugative and phage delivery techniques showing promise. In particular,
Marraffini and colleagues demonstrated the ability of a phage-adapted S. aureus
strain to be killed by introduction of a self-targeting CRISPR-Cas machinery via
phagemid75,150.
The specificity of CRISPR-Cas antimicrobials enables the control of a
species within a microbiome. Tailoring CRISPR-Cas delivery systems also imparts
an additional level of control (e.g., using a species-specific phage). As
microbiomes gain more prominence as crucial ecological cornerstones, the ability
to modulate and selectively remove species will be an important technique that is
impossible with the current suite of antibiotics63. A classic example is the treatment
of Clostridium difficile infections in the human gastrointestinal system151. Such
infections require a high dose of a cocktail of antibiotics that leave the host
microbiome weakened. C. difficile persistor cells often remain, leaving the host
microbiome susceptible to the slightest perturbations that will then prompt
reinfection, resulting in C. difficile often being classified as a chronic infection.
Treatment that can selectively target C. difficile while leaving the host microbiome
undisturbed and therefore able to contribute to suppressing C. difficile growth. This
effect of chronic infection resulting from a weakened microbiome is also found in
other well-known pathogens including certain strains of E. coli and S.
aureus13,67,75,143,151,152. In order to address the key challenges towards deployment
of CRISPR-Cas antimicrobials, this chapter goes through a series of experiments
to investigate promising design strategies for maximizing CRISPR-Cas
antimicrobial potential.

Materials and Methods
Strains and Constructs
BPK2101 from the Joung’s Lab at Harvard University was used as the base
vector for all E. coli experiments97. To create the vectors with other Cas proteins,
the vector was amplified with generic primers. The swap primers for each protein
was used to amplify the sequence found in their respective vectors. The backbone
fragment was then combined with each of the Cas protein PCR fragments via
Gibson Assembly. Each of these products were then amplified with BM_198.f/r
and the respective RNA scaffold fragments were combined with the appropriate
PCR product to give the final base plasmids. In the case of the native
ecoCASCADE, the Cas3 sequence replaced the saCas9 sequence to increase
expression of the exonuclease. Cloning procedure for inserting the guide
sequences followed the protocol described in Joung et al.97 To introduce a second
guide sequence, either a second operon was cloned in using Gibson assembly in
the case of those using sgRNA, or the respective guide combination was ordered
as a spacer-repeat-spacer oligo with the appropriate BsaI overhangs and cloned
in via ligation in the same manner as the single guides. E. coli K-12 (CGSC# 4401)
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was used for all characterization, owing to its F’ genotype for use in M13 phagemid
work.
All work for B. subtilis was performed in the strain NRRL-765. The dual
plasmid system from the Gross Lab was used to integrate CRISPR-Cas machinery
at the lacA (pJMP1, dspCas9 containing) and amyE (pJMP2, sgRNA containing)
loci, respectively74. The dspCas9 sequence in pJMP1 plasmid was replaced with
a catalytically active spCas9 sequence. Natural competence transformation was
used to deliver the vectors in a serialized method, first creating the BMbs001 strain
with the dCas9 operon genome integrated followed by creation of the remaining
strains with natural competence transformation of pJMP2-based plasmids.
To build a library of sgRNAs targeting essential genes for S. aureus, the
backbone of the pCasSA plasmid developed by the Ji Lab at ShanghaiTech153 was
used. This plasmid has the benefit of replicating and expressing in S. aureus
strains episomally. It was then modified by inserting a 2.3 kb section of the phiNM1
genome PCR’d from the Newman strain obtained from ATCC (#25904). We
inserted this section onto pCasSA in between the CAT (chloramphenicol
resistance) and KanR sequences, resulting in the pCasSAvip plasmid. All cloning
procedures for initial construction of the pCasSAvip plasmid have taken place in
E. coli 10-beta (NEB) cells to allow for the successful molecular cloning of the
larger constructs. Transformation of single gRNAs into pCasSA followed the
protocol described in Chen et al.153
Media and culture conditions
All experiments in B. subtilis were performed with Luria Bertani (LB) media. 1%
xylose was used for the induction of the Cas9 protein from its site of genome
integration. Initial screen of E. coli native sgRNAs was performed in LB broth
supplemented with 0.2% arabinose for induction of the crRNA array. All growth of
S. aureus Sa113 was done in tryptic soy broth (TSB) with 5 g/mL chloramphenicol
for selection after transformation of the pCasSA plasmid (and derivatives).
Agar plate screening assay with M13 phage
To obtain CFUs from treatment with Cas-carrying M13 phages, E. coli K-12 strain
was mixed with a MOI (multiplicity of infection) of 1000 M13 phages, translating to
an effective TU (transforming units) ratio of approximately 10:1. Mixtures were
inoculated in media with and without antibiotic (100 g/mL ampicillin or 30 g/ml
chloramphenicol) and with and without 1 g/mL IPTG (for inducing native
ecoCASCADE crRNA array or Cas9) and kept at 37ºC with shaking at 250rpm.
Cultures were then diluted 10x and 50 L was plated onto an agar plate. Colony
counts were taken 16 hours post-spreading.
Flow cytometry measurements
Samples of E. coli were taken immediately following the 12-hour outgrowth in liquid
media (LB +/- 100 g/mL ampicillin, +/- 1 g/ml IPTG). Flow cytometry was
performed on a Guava EasyCyte HT-6 using the InCyte software for analysis.
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Invitrogen LIVE/DEAD BacLight staining was used according to manufacturer’s
protocol. Cutoffs were calibrated based on a sample of exponentially grown (OD
~ 0.5) E. coli K-12 and a sample placed in 200 g/ml ampicillin for 3 hours.
Library screens in S. aureus
To perform the library screen, the initial plasmid library was sequenced by singlydigesting the plasmid to linearize, and then using the ligation sequencing kit
(LSK109) from Oxford Nanopore Technologies and a MinION flow cell to perform
sequencing. Downstream analysis used guppy for base-calling and a custom
alignment search algorithm to identify sequence hits. The method for the library
depletion study is as follows: the plasmid library was transformed via
electroporation into Sa113 cells. Following electroporation, the cells were added
to SOB recovery media for 1.5 hours and then placed in 25 ml TSB media with 5
ng/ml chloramphenicol in triplicate as recommended by Chen et al.153 Cells were
grown at 37oC and 5 ml samples were extracted at 24 hours for plasmid
purification. Isolated and purified plasmids were then taken through the same
sequencing preparation procedure as the initial library.

Results and Discussion
Bacillus subtilis is prone to escape when targeted with spCas9
As B. subtilis does not carry a native CRISPR system, it serves as an ideal platform
to investigate in isolation the toxic effect of CRISPR-Cas induced double strand
breaks. B. subtilis also has a well-studied set of essential genes, which provide a
list of potential target sites. Previous studies have investigated the effect of
targeting essential genes with catalytically inactive (dCas9) 89. Such targeting
resulted in an increase in the lag phase to various degrees depending on the
target. To determine whether introduction of a catalytically active Cas9 changed
the growth response, a similar growth study was performed here with a subset of
31 essential gene targets. The result showed that culture growth behaved similarly
to that of dCas9, exhibiting increases in lag time in strains with sgRNAs targeting
essential genes (Figure 26A). This behavior was also observed to a much lesser
degree on agar plates (Figure 26B). By the 36-hour mark, there was a small but
noticeable change in the colony fullness on 1% xylose (induced) plates, suggesting
a small change due to Cas9 expression. However, this is likely due to the overall
expression of Cas9, which even in the absence of a targeting sgRNA, can still
complex with the empty scaffold RNA and bind randomly to PAM sites throughout
the genome, inducing mild toxicity. This hypothesis is corroborated by the control
colony, which exhibits similar colony size suppression on the 1% xylose plate.
Use of spCas9 in B. subtilis is a helpful exercise to identify areas of
improvements for effective design of CRISPR-Cas antimicrobials. First, the use of
a genome integrated Cas9 locus is likely to express a lesser amount of protein
than from a high-copy plasmid, reducing the overall Cas9 concentration, thereby
reducing activity. Second, this exercise targeted essential genes without
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addressing the SOS response or other DNA repair machinery. Finally, previous
studies and investigation from this work in using CRISPR-Cas as an antifungal
highlight the importance of balancing the kinetic factors in favor of CRISPR-Cas.
Use of the single-turnover spCas9 enzyme is — from a kinetic perspective — the
poorest choice of enzyme for antimicrobial design. Investigation of these three
areas for potential improvement are the subjects of the following sections.
Screening E. coli targets with endogenous CRISPR
The limitation of spCas9 as a single turnover enzyme makes it a poor choice for
CRISPR-Cas antimicrobials. Once the DNA target is cleaved, spCas9 remains in
its cleaved conformation, bound to the remnants of the DNA substrate and unable
to bind to and cleave further targets. In contrast, other Cas types (and indeed
other Cas9 orthologs) will bind and unbind to targets acting as multiple turnover
enzymes. In addition, the Cas3 endonucleases of Type I systems also exhibit
exonuclease activity, first cutting the DNA and then further degrading the DNA
strand at the target site. The principal limiting factor to using Type I (and Type III)
systems is their multi-effector nature that makes them difficult to express
heterologously.
E. coli (K-12 strain) is a suitable organism to investigate Type I systems as
antimicrobials, as it possesses a characterized native Type I CRISPR-Cas system,
termed ecoCASCADE. By expressing a heterologous synthetic CRISPR array
with crRNA sequences targeting GFP gene sequence in a Cas3 knockout strain,
Luo et al. showed substantial suppression of GFP fluorescence13. To study the
effect of essential gene targeting crRNAs, we co-opted the expression system on
the developed pcrRNA.ind vector (Figure 27A), where the heterologous array was
under the inducible arabinose (AraBAD) promoter. To compare the results of the
native system with spCas9, the plasmid backbone of BPK2101 was used to
express spCas9 under a T7 promoter controlled by the lac operon, with sgRNAs
expressed under another T7 promoter (Figure 27A). Growth in selective LB broth
(+100 g/mL ampicillin, +30 g/mL chloramphenicol, respectively) with induction
molecules (0.2% arabinose, 0.1mM IPTG) showed the ecoCASCADE increasing
growth suppression relative to the Cas9 control subset (Figure 27B). Interestingly,
ecoCASCADE not only increased lag time of the strains but also reduced the
growth rate of the strains in many cases. Because the lac operon is notoriously
leaky, the Cas9 expression may have caused bias due to the cloned strains only
containing mutants that were primed for survival in the presence of CRISPR-Cas.
To reduce this bias and to provide a more clinically relevant mechanism of delivery,
we investigated the ability of both systems to be packaged in an M13 lysogenic
phage system.
Phagemid delivery and co-targeting SOS response with CRISPR-Cas
In complex environments such as that of the site of infection in a host or broader
ecosystem, delivery of CRISPR-Cas antimicrobials cannot be achieved through
basic laboratory transformation techniques. The use of the M13 phage for DNA
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delivery into E. coli with an F genotype is a common laboratory technique that can
also be harnessed for packaging and delivering CRISPR-Cas machinery. An
added benefit of using the M13 is that it is lysogenic in standard laboratory
conditions. Results from the assays of phage induction show the ability of cotargeting to increase antibacterial activity but underscore the substantial variability
between target sequences (Figure 27C). Further, keeping selection pressure for
the plasmid containing the CRISPR-Cas machinery leads to a lower colony count.
This result is expected because the longer the CRISPR-Cas machinery persists,
the more likely the SOS system becomes overwhelmed with DNA damage and the
cell resorts to either dormancy or apoptosis.
The M13 phage delivery method was also used when comparing a Cas9
ortholog — saCas9 (from S. aureus) — to the native ecoCASCADE. In this case,
the BPK2101 backbone was used and therefore the selective antibiotic was
switched to chloramphenicol (Figure 27D). Broadly, saCas9 showed a similar
pattern of depletion to the ecoCASCADE, with similar levels of reduction in colony
count. The principal difference between saCas9 and spCas9 is the known multiple
turnover nature of saCas9. Following the kinetic theory of CRISPR-Cas
antimicrobial efficacy, the saCas9 performs as expected, exhibiting similar levels
of targeting to ecoCASCADE, which in the previous growth assay was shown to
outperform spCas9 as an antimicrobial. These results highlight the importance of
using a multiple turnover Cas system for increasing the antimicrobial capability of
CRISPR-Cas.
To identify both loci that are amenable to targeting and the most active
target sequence for sgRNA design requires investigating a substantially larger
combinatorial space than can be reasonably performed with the techniques used
in the previous growth assays. However, selection based on growth (or lack
thereof) presents the opportunity for using a library selection method to identify
promising sgRNA targets.
Library screen to identify common targets and promising alternative
endonucleases in the pathogen Staphylococcus aureus
To investigate a library of 125 guides in the pathogen S. aureus, we followed
the workflow described in Figure 28A. Briefly, oligos containing the desired target
sequence with golden gate overlaps were pooled and cloned into the pCasSA
plasmid. This plasmid library was then transformed into S. aureus Sa113 strain.
Log2 fold changes were calculated by taking the average read count of the three
samples for each sequence and comparing them to the initial pooled sample. The
library screen identified key sequences with significant levels of depletion (Figure
28B). The distribution of sequences with log2 fold depletions > 2 shows that some
genomic loci are more prone to targeting than others (Table 3). For example, dnaJ
(3x), teichB (2x), and gyrB (2x) have multiple sgRNAs that are significantly
depleted in the top 13 sequences shown in Table 3. The remaining 6 sgRNA
sequences in Table 3 appear on separate loci. So while the repeatedly targeted
loci may be more amenable to targeting, the activity of a given sgRNA sequence
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,irrespective of targeted gene, is an equally important metric. Such a diverse
distribution of sgRNAs validates the use of library depletion assays to efficiently
tile sequences across multiple genomic sites.
Characterization of both multiple turnover kinetics and trans nuclease
activity in the Type V family of Cas enzymes is promising for their deployment of
antimicrobials. In particular the asCas12 enzyme has shown a significant amount
of trans activity in vitro53. To investigate its performance as a potential
antimicrobial relative to spCas9, we built a library of 68 asCas12 crRNAs and
compared it to a high performing subset of spCas9 sequences (log2 fold depletion
> 0.5). As highlighted by Figure 28C, the asCas12 library (median sgRNA rank =
53) outperformed the high performing spCas9 library (median sgRNA rank = 70)
with 12 of the 15 most significantly depleted sequences coming from the asCas12
library. This result supports the use of Cas12 family of nucleases for antimicrobial
design. Their multiple turnover nature coupled with trans ssDNA nuclease boost
the rate of DNA damage, thereby rebalancing the kinetic equilibrium in the favor of
the CRISPR-Cas system and cell death.

Conclusions
The design of CRISPR-Cas for antimicrobial applications requires appropriate
selection of a highly active target sequence on an available genome sequence with
a multiple turnover enzyme preferably with trans nuclease activity. In addition, the
co-targeting of defense systems, namely the SOS response, is important for
increasing potency to relevant levels. Finally, the delivery via phage represents a
unique ability to multiplex the lytic properties of some phages with the growth arrest
and/or apoptosis caused by self-targeting CRISPR-Cas. This study lays out a
systematic workflow for screening and characterizing antimicrobial targets. Using
a library screen of tiled essential genes can narrow down the selection of guideRNA sequences to a select number that can then be characterized with
combinations of pre-determined highly active defensive (SOS) targeting guides.
These combinations can be then packaged into a phage and assayed for their
killing efficiency in various environments, particularly non-selective conditions that
are more relevant to clinical application.
Ultimately, the ability of bacteria to inevitably evolve away via mutations to
target sites will require multiple guide-RNA designs to be developed as a sort of
cocktail therapy to prevent the formation of persistent mutant genotypes. This is
an area of particular strength for CRISPR-Cas antimicrobial design and
implementation, as the synthesis of a variety of guides is both rapid and cheap,
making them ideal for combating time-sensitive pathogen outbreaks.
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CHAPTER SEVEN CONCLUSIONS AND RECOMMENDATIONS
FOR FUTURE WORK
In this dissertation a pipeline was built for rapid identification of putative target sites
for manipulation by CRISPR-Cas enzymes in varied types of genomic data, from
population-level metagenomes to well-annotated model organisms. Further, the
capability of protein modeling to enhance off-target activity prediction was
investigated. Mining of the entirety of the available prokaryotic genomic data in
NCBI’s database to identify features of novel CRISPR-Cas systems in unstudied
organisms completes the computational portion of the work. These exercises laid
the groundwork to apply CRISPR-Cas as an antimicrobial. When designed
properly, with careful attention to the target organism, guide-RNA(s) selection, Cas
protein, and delivery mechanism, CRISPR-Cas is a highly capable system with
inherent specificity. The importance of these features was further underscored in
various experimental conditions and assay types that identified key mechanisms
of resistance and persistence.
This work opens the combinatorial space of CRISPR-Cas enzyme and
target design to increase antimicrobial potency of these systems, particularly as it
applies to modulation of diverse microbiomes. In order to enhance the toolkit, key
improvements at each step of the design process are suggested in the sections
that follow; these will build upon a strong foundation of work set about by this
dissertation.

Expanding population engineering computational workflow
The ability to design CRISPR-Cas tools for engineering microbiomes and other
mixed populations is a powerful feature of the CASPER platform developed in this
work. As understanding and capabilities to sequence and annotate metagenomes
more precisely become widespread, the need for a more robust and specialized
set of algorithms for dealing with these datasets will be necessary. The integration
of CASPER into a user-friendly software platform for a broad audience is a critical
development. The wide-ranging applications of CRISPR-Cas also demand
consistent feedback from the research community to keep the algorithms relevant
to experimentalists. Of note, the use of base-editors for modifying SNPs and the
use of Cas12/13 nucleases for sequence detection in unknown samples are two
applications uniquely suited to the bioinformatic capabilities of CASPER 60,61. In
addition, the foundations of CASPER’s target identification and on/off-target
activity algorithms can be combined with techniques in phylogenetic analysis to
more precisely predict potential off-target activity within a microbiome. This will
facilitate the design process for microbiome modulation, a promising new area of
research that is still in its infancy.

Increased modeling accuracy with Rosetta parameterization
Using a Rosetta framework to predict R-loop energetics without the need for
computationally costly molecular dynamics (MD) simulations allows such ternary
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complex simulations to be used for approximating off-target activity46. The work
presented in this dissertation highlights the capabilities of such a method,
demonstrating the ability to rely on biophysical principles rather than opaque
machine learning rules to evaluate activities of guide-RNAs. This enables the
methodology to be expanded to other single-effector Cas proteins that may require
re-training in the machine learning paradigm. However, the work here can be
greatly expanded upon in three key directions: 1) increasing the number of Cas
nucleases and accompanying datasets, 2) re-parameterization of Rosetta
algorithms to streamline computation and more accurately assess R-loop
energetics, and 3) establish an accessible pipeline for accessing Rosetta-enabled
predictions.
First, the current study relied on two seminal datasets using three Cas
nucleases. There currently exists a substantial number of off-target assays that
can be examined using this framework but requires significantly more
computational time to perform such analysis. By investigating other experiments,
further insight can be obtained on both the accuracy of the model and the role of
certain factors in contributing to absolute off-target activity. Future experimental
assays can be designed with these parameters in mind to design more precise
and accurate off-target assays that can be utilized for clinical applications.
Second, the use of the default settings in Rosetta were chosen to limit the
vast combinatorial space of parameter decisions. Recently, updates to the Rosetta
suite—including an upgraded RNA structure mutation algorithm—open the
possibility for this space to be systematically explored 154. Optimistically, these
improved algorithms may further reduce the need for structure averages to be used
to minimize the degree of local energy well fluctuations.
Finally, this prediction methodology is most useful when combined with an
easily accessible portal to investigate potential off-targets of a guide-RNA
sequence. The CASPER software developed as part of this dissertation provides
an excellent platform to integrate such a feature, but due to the limited number of
sequences currently analyzed by Rosetta, is not useful for most applications. The
combination of increasing the number of guides analyzed with future access to a
customized Rosetta/CRISPR simulation server will ultimately provide a valuable
research to the wider research community.

Expanding principles to pathogenic fungi and validating
mechanisms of delivery
The model yeast Saccharomyces cerevisiae used in this work is the ideal organism
for investigating principles of design by providing a well-curated genome for
investigation. This facilitated the identification of key features of CRISPR-Cas
antifungal design, principally the importance of kinetic factors when such systems
are inducible or transiently expressed, as would be relevant for deployment in
clinical applications. Counteracting the DNA repair machinery is of importance to
increase antifungal potency, particularly with homologous recombination
machinery in S. cerevisiae. Other pathogenic fungi present their own unique
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challenges with respect to their DNA repair mechanisms. Large ploidy numbers
and multi-nucleated cells are of concern, presenting a greater challenge for
CRISPR-Cas induced gene disruption147,155,156.
Therefore, in these new
pathogens, targeting replication/reproduction/and growth phenotype machinery
may be equally important towards ensuring the maximum antifungal potential.
Library screens such as the ones utilized in this work will play a critical role in these
investigations, as they are a rapid and cheap way to reduce the design space for
potential target combinations.

Controlling the microbiome through selective species
The design rules developed in this work for increasing the efficacy of CRISPR-Cas
antimicrobials demonstrates key areas for systematic improvement, focusing on
further tilting the kinetic equilibrium to favor the induction of cell death. A key
variable that must be explored is the interplay of such perturbation within the scope
of the microbial community. In particular, the highly selective removal of a certain
species has been confined to synthetically reconstructed communities but is now
possible in wild communities157. While pathogen/invasive species removal is a
clear need, the more nuanced modulation of relative species abundance is a new
research direction enabled by the CRISPR-Cas technology. Developing a greater
understanding of the full spectrum of CRISPR-Cas mediated growth phenotypes,
particularly in the context of a microbiome will need to be further explored to
actualize microbial community control. Ultimately, the combination of the versatile
CRISPR-Cas system with the increased understanding of the ability of microbial
communities to transform ecosystems has the potential to be a transformative
pairing.
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Figure 1 CRISPR-Cas adaptive immunity.
Figure adapted from Semenova and Severinov in "Evolutionary Biology: Self/Nonself Evolution,
Species, and Complex Traits Evolution, Methods and Concepts”
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Figure 2 CRISPR-Cas types.
Types of CRISPR-Cas systems and their mechanisms of interaction with target DNA. Adapted
from Jackson et. al. (2017) “CRISPR-Cas: Adapting to change.”
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Figure 1
A

B
CASPER algorithm
R2 = 0.4425
CRISPRscan
R2 = 0.4186

100

0.8

Predicted Score

Predicted score

80

CASPER algorithm
R2 = 0.5091
Hsu matrix
R2 = 0.2071

1.0

60
40
20

0.6
0.4
0.2

0

0.0
0%

20%

40%

60%

80% 100%

0.0

% rank activity

0.2
0.4
0.6
0.8
1.0
Experimental relative indel

Figure 3 Correlation of CASPER algorithms.
(A) Comparison of CASPER on-target algorithm with CRISPRscan against experimental data
obtained from Moreno-Mateos et al. 94. The % rank activity (on-target) is obtained by ranking the
activity of a sequence with respect to the rest of other sequences in the sample set. (B)
Comparison of CASPER off-target algorithm with Hsu matrix method against experimental data
obtained from Hsu et al. (off-target) 95. The experimental relative indel (off-target) is determined
by dividing the absolute indel % of the off-target site by the indel % of the targeted site. For
example, a gRNA that has a 25.0% indel at the targeted site and 1.0% at the off-target site gives
a 4% (or 0.04) relative indel.
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Figure 4 PAM motif appearances.
Appearances of PAM motifs for three common Cas endonucleases (spCas9, asCpf1, and
spCas9-VRER variant) across a select number of non-model organisms including (A) eukaryotes
and (B) prokaryotes. Organism abbreviations: yli: Yarrowia lipolytica, ang: Aspergillus niger, sce:
Saccharomyces cerevisiae gmx: Glycine max (soybean) osa: Oryza sativa Japonica (rice) tre:
Trichoderma reesei, cac: Clostridium acetobutylicum, cace: Clostridium aceticum, cbe:
Clostridium beijerinckii, cbut: Clostridium butylicum, ccb: Clostridium cellulovorans, ckl:
Clostridium kluyveri, csb: Clostridium saccharobutylicum, csr: Clostridium
saccharoperbuytlacetonium, cth: Clostridium thermocellum (ATCC 27405), ctx: Clostridium
thermocellum (DSM 1313), cce: Clostridium cellulolyticum, tro: Thermomicrobium roseum, ttm:
Thermoanaerobacterium thermosaccharolyticum (DSM 571), tsh: Thermoanerobacterium
saccharolyticum, tto: Thermoanaerobacterium thermosaccharolyticum (M0795), dha:
Debaryomyces hanseii, med: Megasphaera elsdenii, ate: Caldicellulosiruptor bescii, ccl:
Clostridium clariflavum, cgl: Cornyebacterium glutamicum, clj: Clostridium ljungdahlii, sco:
Streptomyces coelicolor, slv: Streptomyces lividans, samb: Streptomyces ambofaciens, scb:
Streptomyces scabiei, salb: Streptomyces albus.
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Figure 5 Multitargeting analysis.
Multitargeting analysis for each repeated sequence plotted by the number of times it appears
within a gene (blue-green) and throughout the genome (black) for (A) C. thermocellum using
spCas9, (B) C. thermocellum using asCpf1, (C) C. cellulovorans using spCas9, and (D) C.
cellulovorans using asCpf1. Parentheses indicate the number of repeated sequences. (E) The
distribution across the genome of C. thermocellum using a set of 4 representative non-unique
sequences, including gRNA8: ACGTCAAACCTTTGGGCATT, gRNA147:
GCAGAGCTGGATGAACATCT, gRNA291: TCCGTCGGTATCGGCTCCTC, and gRNA858:
GACGGAGTCGGTTCATCAGA. Blue-green lines indicate appearance within a gene sequence
while black lines represent appearances in un-annotated regions.
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Figure 6 Multitargeting cellular processes.
Annotated cellular processes targeted by repeated sequences for (A) C. thermocellum, (B) C.
acetobutylicum, and (C) C. kluyveri.
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Figure 5
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Figure 7 Population targeting.
Comparison of the number of shared targets between (A) C. thermocellum and other
thermophiles and (B) C. cellulolyticum and other mesophiles. The green portion of the bar
represents the number of sequences that appear in both genomes but are unique within each
genome. White portion of the bar represents the number of sequences that appear in both
genomes and is repeated within one or both genomes being compared. (C) A hypothetical
synthetic consortium of three different Clostridial species with synergistic metabolisms. (D) The
Venn diagram represents a three-way comparison of these organisms with the numbers of
sequences shared among the genomes shown at the intersections.
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Supplementary Figure S1. (A) Nucleotide indexing of the target sequences for Cas9 and Cpf1 used in the
development of the CASPER on- and off-target algorithms. ‘N’ stands for any nucleotide. (B) Demonstration
of the on-target algorithm on a sample target sequence. The on-target score has a range of 0-100, with 100
being most active. (C) Demonstration of the off-target algorithm on a sample off-target sequence. The offtarget has a range of 0-1, with 1 indicating a high probability of off-target activity.
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Figure 8 Algorithm schematic.
(A) Nucleotide indexing of the target sequences for Cas9 and Cpf1 used in the development of
the CASPER on- and off-target algorithms. ‘N’ stands for any nucleotide. (B) Demonstration of
the on-target algorithm on a sample target sequence. The on-target score has a range of 0-100,
with 100 being most active. (C) Demonstration of the off-target algorithm on a sample off-target
sequence. The off-target has a range of 0-1, with 1 indicating a high probability of off-target
activity.
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Figure 9 PAM density scoring table.
Scores are the derived from the fold-change in cleavage. Efficiency of the sequence from the 0
PAM control100.
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Figure 10 Rosetta computational workflow.
A 20-structure was first generated with the Rosetta ‘relax’ algorithm. The structures with the
lowest Rosetta Energy Units (REU) for the total structure were then used as base structures for 5
ensembles. The base structure of each ensemble was then mutated with the ‘rna_mutate’
algorithm to match the on-target structures. These structures were then passed through both
‘relax’ and ‘minimize’ algorithms. The relaxed structure was passed through another round of
mutation to generate the off-target structures, which were further minimized. The DNA molecules
of the minimized structures were then successively truncated and scored to generate the proxy
for the thermodynamic path of R-loop formation.
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Figure 11 On target activity lack of correlation.
Using the dataset from Moreno-Mateos et al.31 neither RNA, DNA, or total structure scores were
able to recreate correlation of the experimental results from this study, suggesting the protein
simulation is a poor approximation of absolute activity and should be used only to determine
relative off-target activity where an R-loop simulation proxy can be utilized. Shown here is the
cumulative nucleic acid Rosetta Energy Units and the relative sgRNA activity rank.
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Figure 12 Truncation schematic.
RNA truncation method to simulate movement across the R-loop transition for (A) Cas9 binding
and (B) Cas12 binding with sample truncation structures. Truncating the RNA-binding DNA can
be used as an approximation of R-loop formation. The difference between the on-target structure
at the corresponding truncation is used to subtract the contributions to the REU value from the
addition of additional residues to the structure. The ΔΔG and ΔG equivalents used in the
truncation plots are generated from the difference between the change of the two structures and
summation of the changes respectively.

Table 1: PDBs used in Rosetta study.
RCSB

Cas

PAM

Enzyme

RNA

Targeted

Complementary

length

DNA length

DNA length

5F9R

spCas9

TGG

116

30

30

5XUS

lbCas12

TTTA

39

29

9

5XUT

lbCas12

TCTA

39

29

9

5XH6

asCas12

TATA

42

29

10

5XH7

asCas12

TCCA

42

29

10
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A

50
45
40

R = -0.5, p < 2.2e-16

RosCas Score

35
30
25
20
15
10
5
0
0.0

0.2
0.4
0.6
0.8
Maximum Likelihood Estimation (MLE) DNA cleavage

B

1.0

C
Method

True positive rate

AUC = 0.860

AUC from ROC

RosCas (this study)

0.860

FNN_3layer

0.755

CNN_std

0.834

Logistic regression

0.780

Random forest

0.701

GDT

0.707

CFD

0.746

MIT

0.744

CROP-IT

0.686

CCTop

0.655

MIT-web

0.628

False positive rate

Figure 13 RosCas correlation statistics.
Comparison between RosCas prediction and experimental data for off-target analysis using Cas9
structures. Using the Rosetta parameters described in Equation 3.1 a relatively low spearman
correlation (R=0.5) but a high area under curve (AUC) from the relativistic operating curve (ROC)
was obtained that outperforms previous algorithms, including state-of-the-art convolutional neural
networks. (A) Correlation between RosCas and MLE. (B) Relative operating characteristic curve.
(C) Comparison between RosCas algorithm with other state-of-the-art techniques using the same
Hsu et al. dataset30,36,44,45,120.
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Figure 14 Ensemble sensitivity.
Pearson (Blue) and Spearman (Red) Ensemble Correlations of spCas9 Single Mismatch Dataset
(Hsu et al, 2013)36.
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Figure 15 lbCas12 correlation and statistics.
Fitting results from Cas12 structures to experimental data. (A) The size and degenerate target
site nature of the Kleinstiver et al. dataset35 creates poor correlation statistics. (B) Although a
mismatch occurred 2 bases from the PAM site, the thermodynamic effect was delayed by
approximately 7 nucleotides, suggesting mismatches can be more than just locally destabilizing.
(C) By using the simulation scores as a guide, the difference of “targetablility” between different
sites across the genome can be elucidated, highlighting this method’s ability to interrogate
relative loci activity creating a genome-wide profile of activity for future guide-RNA design.
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Figure 16 Schematic of CASPERpam workflow.
The previously identified CRISPR spacerome is re-BLASTED to obtain adjacent sequence
regions, which then are aligned and classified into motif categories.
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Figure 17 CASPERpam algorithm for identifying PAM sequences.
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Figure 18 Predicted PAM for validated species.
Predicted PAM sequences for experimentally validated species including (A) Pseudomonas
aeruginosa, (B) Escherichia coli, (C) Acinetobacter baumannii, (D) Streptococcus pyogenes, (E)
Clostridium difficile, (F) Lachnospiracae bacterium, (G) Bacillus halodurans, (H) Streptococcus
thermophiles, (I) Treponema denticola, (J) Neisseria meningitides, (K) Campylobacter jejuni, and
(L) Staphyloccocus aureus.
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Figure 19 Predicted PAM sequences and categorization.
(A) Mapping PAM sequence categories to CRISPR/Cas types. (B) Common patterns and
assigned 5’ PAM sequence categories. (C) Common patterns and assigned 3’ PAM sequence
categories. (D) Number of species per 3’ PAM category.
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Table 2: Top species by confidence score.
Genus

Species

Cas type

PAM

Exp. PAM

Consensus

Relative

Qualitative

PamCoS

assessment

Pseudomonas

aeruginosa

CAS-I-F

5'

CC

cS

100.0000

match

Acinetobacter

baumannii

CAS-I-F

5'

CC

CC

59.3357

match

Salmonella

enterica

CAS-I-E

5'

-

ANG

30.0805

Streptococcus

agalactiae

CAS-II-A

3'

-

NgG

24.6686

Escherichia

coli

CAS-I-E

5'

AWG

aNS

20.4289

Streptococcus

suis

CAS-II-A

3'

-

NgR

16.7142

Salinispora

arenicola

CAS-I-E

5'

-

SNNS

16.1926

Klebsiella

pneumoniae

CAS-I-E

5'

-

aWg

14.3394

Neisseria

meningitidis

CAS-II-C

3'

NNNNGATT

NNNNNMH

13.2987

Vibrio

cholerae

CAS-I-E

5'

-

MM

9.4119

Leptospira

interrogans

CAS-I-B

5'

-

ATG

8.5312

Listeria

monocytogenes

CAS-I-B

5'

-

ccW

8.3762

Clostridium

botulinum

CAS-III-B

5'

-

TNW

8.2882

Fusobacterium

nucleatum

CAS-I-B

5'

-

YNW

8.2191

Enterococcus

faecalis

CAS-II-A

3'

-

NgRNW

7.2013

Clostridium

difficile

CAS-I-B

5'

CCW

WNNNW

6.5629

Salinispora

pacifica

CAS-I-E

5'

-

SNNS

6.4865

Pasteurella

multocida

CAS-I-F

5'

-

Cc

6.3487

Moraxella

catarrhalis

CAS-I-F

5'

-

WNNY

5.5702

Leptospira

santarosai

CAS-I-E

5'

-

AaG

5.5368

Bifidobacterium

longum

CAS-II-C

3'

-

SNNS

5.2296

Serratia

marcescens

CAS-I-F

5'

-

aMS

5.0828

Clostridioides

difficile

CAS-I-B

5'

-

MNW

4.4906

Bifidobacterium

breve

CAS-I-C

5'

-

TTC

3.9543

Streptococcus

thermophilus

CAS-II-A

3'

NNNNGWWT

NNWNWa

3.8955

Methanosarcina

mazei

CAS-I-B

5'

-

Tta

3.5871

Streptococcus

pyogenes

CAS-II-A

3'

NGG

NNR

3.4889

Yersinia

pseudotuberculosis

CAS-I-F

5'

-

CC

3.4491

Fusobacterium

necrophorum

CAS-II-A

3'

-

NGG

3.3977

Propionibacterium

freudenreichii

CAS-I-U

5'

-

SSaN

3.0403

Campylobacter

coli

CAS-I-B

5'

-

TNNNNNW

2.9907

Clostridium

novyi

CAS-I-B

5'

-

TNW

2.8437

Corynebacterium

ulcerans

CAS-I-E

5'

-

AC

2.8430

Salinispora

tropica

CAS-I-B

5'

-

SNNS

2.8154

Lactobacillus

paracasei

CAS-II-A

3'

-

TNNAA

2.6750

Aggregatibacter

actinomycetemcomitans

CAS-I-C

5'

-

C

2.6473

Treponema

pedis

CAS-II-C

3'

-

NNNWA

2.6391

Corynebacterium

striatum

CAS-I-E

5'

-

AM

2.5033

Lactobacillus

rhamnosus

CAS-II-A

3'

-

NNNWR

2.4688

Xenorhabdus

nematophila

CAS-I-E

5'

-

AAg

2.4337

Campylobacter

jejuni

CAS-II-C

3'

NNNNRYAC

NNNNWNA

1.5839

no

Lachnospiraceae

bacterium

CAS-V-A

3'

TTTV

TNH

0.8278

strong partial

Treponema

denticola

CAS-II-A

3'

NAAAAN

NNNWW

0.6881

weak partial

Staphylococcus

aureus

CAS-III-A

5'

NNGRRT (3')

TNN

0.2079

no

Bacillus

halodurans

CAS-I-C

5'

YYC

WNNTTN

0.1347

strong partial

match

no match

strong partial

weak partial

strong partial

Lower case letter indicates a frequency between 0.25 and 0.5. Degenerate Codes: W = A/T; S =
G/C; R = A/G; Y = C/T; K = G/T; M = A/C; B = not A; D = not C; H = not G; V = not T.
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Figure 20 Schematic of co-targeting and agar serial dilution heat maps.
Co-targeting mechanism for increased growth suppression/cell death. (A) Targeting a single
essential gene locus results in cell survival due to active DNA repair machinery. (C) Co-targeting
parts of the DNA repair response reduce the ability to repair legions at essential and defensive
sites, increasing lethality via essential gene knockout and DSB-induced apoptosis. (B, D) Heat
maps of serial dilution results on agar plates of essential and defensive gene combinations. Noninduced strains grown on glucose plates are indicated in red while induced Cas9 strains grown on
galactose pads are indicated in purple. Larger colony size is represented by darker coloration.
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Figure 21 Detailed characterization of 18 strains.
(A) All selected strains exhibit extreme loss of growth on galactose (Cas9-induced) plates. (B) In
liquid media however, 3 strains exhibit a return to a normal growth phenotype as compared to the
strain targeting two defensive genes (Vip46 RAD51/RAD52). Three strains show a growth lag but
begin to enter exponential growth after 48 hours outgrowth. The remaining 11 strains show
growth inhibition. (C) Selected strains exhibit a viability profile in between the no carbon
(starvation) and antibiotic profiles as determined by flow cytometry.
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Figure 22 Effect of inoculation concentration on killing efficiency.
(A) Inoculation of three of our high performing strains using either OD = 0.05 or OD = 0.2. Higher
concentration of cells at the outset of the experiment can overwhelm the population by
decreasing lag time, thereby increasing both antibiotic tolerance and tolerance to growth
suppression by our CRISPR-Cas antifungal design. (B) Flow cytometry measurements confirm
the increase in viable cells in the high inoculation scenario.
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AGAACAACATATATCAGA ----------------------------------------------------------- AGTCAGTCGTTGATG
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CAACTAATTAAGTAATGTCTGCTCCAGAAGCTCAACAACAAAAGAG AGGTGGTTTCGGTGGCCGTAACAGAGGCCGTCCAAACAGAAGAGGA 98.5%
CAACTAATTAAGTAATGTCTGCT --------------------------------- GGTGGCCGTAACAGAGGCCGTCCAAACAGAAGAGGA 1.5%

Vip60
RAD51
AGAACAACATATATCAGAGTCACAGCTT --CAGTACGGGAACGGTTCGTTGATGTCCACTGTACCAGCAGACCTTTCACAGTCAGTCGTTGA 72.8%
AGAACAACATATATCAGAGTCACAGCTT TTAAGTACGGGAACGGTTCGTTGATGTCCACTGTACCAGCAGACCTTTCACAGTCAGTCGTTGA 15%
AGAACAACATATATCAGAGTCACAGC --------------------------------------------------------- TGTCGTTGA 12.2%

RPS21
GATCATGTCTCAAGCTGTTAATGCCAAGAAGAGAGTTTTTAAGACCCACTCTTACAGAGGTGTCGATTTGGAAAAATTGTTGGAAATGTCCA

100%

Figure 23 Targeted amplicon sequencing results.
Oxford Nanopore ligation sequencing kit was used to sequence PCR amplification of targeted
genes. Single-targeted strains show low-levels of mutation with the exception of the defensive
genes, in particular RAD51. As seen in the sequence alignments provided for Vip10, Vip43, and
Vip60, mutants are dominated by large (>20bp) deletions, although mutation frequency is
relatively low and heterogeneous. Essential genes in double-targeted strains show no significant
mutation with the exception of ACC2 in Vip48.
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Figure 24 Single plasmid library and characterization.
(A) Workflow for the library depletion assay of 184 sgRNAs. (B) Volcano plot of a library
depletion/enrichment assay of 185 guide-RNAs spanning 37 essential genes. Library was
transformed into S. cerevisiae BY4741 and grown for 48h in selective media with and without 5
ug/ml tetracycline (for Cas9 induction). Log2 fold-changes represent the change in read counts
between the control culture and induced culture. Fold-changes were averaged over 4 replicates.
Significantly depleted (p-value < 0.05 and fold-change < -0.6) sgRNA sequences are highlighted
in red. RPL37A (yellow, red outline) was the only gene to appear multiple times in the cutoff
region, which agrees with our results in our two-plasmid system screen. (C) Growth
characterization over 60 hours of three high performing targets identified by the library screen. In
all cases co-targeting with RAD51 sgRNA increases growth suppression.
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Figure 25 Characterization of library-identified sgRNAs.
Effect of temperature and tetracycline concentration on single essential genes identified from
library screen. Increasing dosage of tetracycline increases expression of Cas9 and results in
increased growth suppression. The difference of growth suppression between 3 and 5 ug/ml
tetracycline is minimal. Increasing temperature to the optimal spCas9 temperature (37ºC) results
in only a slight increase in killing efficiency.
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Figure 26 Growth characterization of B. subtilis.
Measurements in (A) liquid LB media containing 1% xylose using OD (B) agar plating show
robust escape mechanisms in B. subtilis in the presence of Cas9 with sgRNAs targeting essential
genes. Cas9 is expressed under the Pxyl promoter and strongly induced in the presence of 1%
xylose. Increased lag time compared to the empty sgRNA vector and a slight decrease in colony
size compared to the media absent xylose suggest some effect of the Cas system on growth.
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Figure 27 Characterization of saCas9 and ecoCASCADE.
E. coli was used as a subject to compare the differences in utilizing endogenous or heterologous
Cas systems. (A) Vectors used for expressing the native crRNA array (pcrRNA.ind65) and the Cas
protein with its respective sgRNA (BPK2101 97). (B) Liquid growth (LB+amp/cm) of Cas9 (orange)
and ecoCASCADE (blue) carrying strains with sgRNAs targeting essential gene loci. Control
strains containing the empty plasmid backbones are shown in red (BPK2101) and green
(pcrRNA.ind) respectively. (C) Colony counts post-12-hour liquid outgrowth from strains infected
with M13 phages carrying crRNAs targeting essential genes and co-targeted with a crRNA
targeting the recA gene using the ecoCASCADE system. Liquid outgrowth samples were plated
on either LB (orange) or LB+amp (purple) plates to assess the effect of removing selective
pressure for maintaining the CRISPR-Cas machinery. (D) Colony counts post-12-hour liquid
outgrowth of strains infected with M13 phages carrying saCas9 machinery targeting essential and
essential + recA sgRNAs.
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Figure 28 Library depletion assays in S. aureus.
(A) Workflow for implementing a library depletion assay in S. aureus. (B) Library results from
spCas9 system show significant log2 fold change (<-2) for a subset of 16 guides after 24-hour
outgrowth in selective media (5 ug/ml chloramphenicol). (C) asCas12 library of guides
significantly outperforms the high-performing spCas9 library subset, suggesting asCas12 is a
more potent choice of targeted antimicrobial.
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Table 3 Log2 fold changes for most depleted sgRNA sequences.

Gene-sgRNA # Log2 fold change
dnaJ-5 -6.2596621
teichB-3 -4.9159227
glnA-5 -4.7822436
teichB-2 -4.5885362
gyrB-2 -3.6478624
dnaJ-4 -3.3721395
prsA-3 -3.2666951
fabF-5 -3.1416913
gyrB-5 -3.0404854
trxB-3 -2.9974578
dnaJ-2 -2.9413006
ftsA-5 -2.6357435
gmk-2 -2.5402509
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